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1. INTRODUCTION 
 
HERBAL MEDICINES 
The term “medicinal plant” include various types of plants used in herbalism 
("herbology" or "herbal medicine"). It is the use of plants for medicinal purposes, and 
the study of such uses. The word “herb” has been derived from the Latin word, “herba” 
and an old French word “herbe”. [1] 
We have so much benefit from plants in their most natural state. The famous 
father of medicine, Hippocrates was quoted as saying: Let thy food be thy medicine, 
and thy medicine shall be thy food. We should be so grateful to plants for the food, 
health, and healing remedies that they have provided, and continue to provide us with. 
They have been used as medicine and as diverse healing modalities for anything from 
external to internal infections, mental and emotional imbalances, as well as for every 
physical illness. [2] 
Herbal medicines were used in ancient Chinese, Greek, Egyptian and Indian 
medicine for various therapeutic purposes. The history of herbal medicines is as old as 
human civilization. The knowledge of herbal medicines has been transferred from 
generation to generation and this is the root of allopathic medicine and its derivatives. 
According to World health organisation, it is estimated that 80% of the world’s 
population still depend mainly on traditional medicines for their health care.  
The traditional knowledge and experiences supports the discovery of variety of 
natural and semisynthetic compounds. Nowadays, the usage of medicinal plants has 
increased day by day not only for primary healthcare but also to treat chronic diseases 
like cancer, diabetes mellitus, liver disorders, rheumatic pains etc. 
Thus it is a well-known fact that the traditional systems of medicines has always 
played important role in meeting the global health care needs. They are continuing to 
do so at present and shall play major role in future as well. The medicinal system which 
are considered to be Indian in origin or the systems of medicine, which have come to 
India from outside, got assimilated in to Indian culture are known as Indian systems of  
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medicine. India has the unique distinction of having six medicinal systems of in this 
category. They are Ayurveda, Siddha, Unani and Yoga, Naturopathy and 
Homoeopathy. Though Homoeopathy came to India in 18th Century, it completely 
assimilated in to the Indian culture and got enriched like any other traditional system 
hence it is considered as part of Indian Systems of Medicine. Apart from these systems 
there are large number of healers in the folklore stream who have not been organized 
under any category. [3] 
Traditional systems of medicine continue to be widely practised on many 
accounts. Population rise, inadequate supply of drugs, prohibitive cost of treatments, 
side effects of several synthetic drugs and development of resistance to currently used 
drugs for infectious diseases increased the use of plant materials as medicines for a 
wide variety of human diseases. [1] 
Pain and fever are being the most common complaints associated with 
inflammation. The NSAIDs used in the inflammatory conditions do not cure or remove 
the underlying cause of the disease but they only modify the inflammatory response to 
the disease. Large numbers of NSAIDs are available in the market with their advantages 
and disadvantages. Though there are effective drugs like aspirin, indomethacin, 
phenylbutazone, etc., these drugs are not entirely free of side effects and have their own 
limitation. Thus there is a need to develop newer and safer drugs. NSAIDs use is 
frequently limited by gastrointestinal side effects, ranging from dyspepsia to life 
threatening bleeding from ulceration. It is believed that NSAIDs by inhibiting COX 
pathway causes inhibition of prostaglandins synthesis, which are responsible for 
maintaining gastric mucosal integrity.  
Pathogenic bacteria have always been thought to be a considerable cause of 
morbidity and mortality in humans. Although different pharmaceutical companies have 
introduced a number of new anti-bacterials in the last years, but resistance to these 
agents has also increased and has now become a worldwide problem Herbal medicines 
used in ayurveda remain the major source of health care for the world’s population. 
World health organisation has recognized herbal medicine as an important building 
block for primary health care of vast countries like India. [4] 
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SIDDHA MEDICINE 
Siddha medicine is the traditional medical system that is widely practised in 
South India. It was enriched with ethnic medical knowledge of Tamil people, native of 
rich biodiversity zone of Western Ghats. [5] 
It is believed to be originated more than 10,000 years ago. Siddha system 
consider human and nature as a part of closed system. Palm leaf manuscripts says that 
the Siddha system was first described by Lord Shiva to his wife Parvathy. Parvathy 
explained all this knowledge to her son Lord Muruga. He explained all these knowledge 
to his disciple sage Agasthiyar. Agasthiyar taught the knowledge about siddha to 17 
Siddhars and they spread it to the human beings. 
The word Siddha came from the word ‘siddhi’. The persons who attained this 
are called Siddhars. They wrote literatures in classical Tamil language for all branches 
of science and it is mainly practiced in southern part of India. [6] 
FUNDAMENTAL PRINCIPLES OF SIDDHA MEDICINE  
The universe consists of two essential entities, i.e. matter and energy.  The 
Siddha medicine called them Siva and Shakti. Matter cannot exist without energy 
inherent in it and vice versa.  The two co-exist and are inseparable. Their names are 
Munn (solid), Neer (fluid), Thee (radiance), Vayu (gas) and Aakasam (ether). These 
five elements (Bhutas) are present in every substance, but in different proportions.  
Earth, water, fire, air and ether are symbols of these 5 elements. 
The human being is made up of these five elements, in different combinations.   
The physiological function in the body is mediated by three substances (dravayas), 
which are made up of these five elements.  They are Vatham, Pitham, and Karpam. In 
each and every cell of the body these three doshas i.e. vatham, pitham, karpam co-exist 
and function harmoniously. The tissues are called dhatus. Akasam and Vayu forms 
Vatham and it controls the nervous actions such as movement, sensation, etc.  Pitham 
is formed by Thee and controls the metabolic activity of the body, digestion, 
assimilation, warmth, etc. Kapam is formed by Munn and Neer and controls stability.  
When their equilibrium upsets diseases sets in. [7] 
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Treatment is aimed at restoring balance to the mind-body system. Diet and 
lifestyle plays a major role not only in maintaining health but also in curing diseases. 
This concept of the Siddha medicine is known as pathiam and apathiam, which is 
essentially a list of do's and don'ts. [8] 
Generally the basic concepts of the siddha medicine and the ayurveda medicine 
are similar. The important difference is that the siddha medicine identifies the 
predominance of vatham, pitham and karpam in childhood, adulthood and old age. But 
in ayurvedic medicine, it is totally reversed that is, it identifies the dominance of 
karpam, vatham, pitham in childhood, old age and adults. [9] 
KABASURA KUDINEER CHOORNAM 
It is a compound formulation consisting of fifteen herbal ingredients. It is 
commonly used for the treatment of fever with or without respiratory infection. It was 
prescribed in large during the epidemic of Swine flu as a prophylactic and media reports 
gave a renaissance to this official Siddha formulation. Siddha medicinal preparations 
have been classified as 32 internal and 32 external medicinal forms and choornam is 
one among the internal medicinal form. The current drug is further classified as 
kudineer choornam which means a drug to be made into decoction and consumed. [10] 
Kudineer  
Kudineer is the name given to the Siddha formulation in which the whole plant 
(plants) or the particular part of plant (plants) are grinded into coarse powder. The 
obtained preparation is called ‘choornam’. It is then made into kudineer by adding 
water and heated till water reduces to 1/4th or 1/8th of its volume. It is then filtered and 
filtrate is used. Dose of the kudineer is generally 30 ml before food, three to four times 
a day. Lifetime of prepared kudineer is 1 Samam (3 hours). The method of preparation 
of kudineer is simple and the phytoconstituents do not undergo any major change while 
processing and preparation, unlike other traditional formulations. [11]  
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INFLAMMATION 
Inflammation is the word obtained from the Latin word inflammo. It is a part of 
the complex biological response of body tissues to various harmful stimuli, such as 
pathogens, damaged cells, or irritants. Inflammation is a protective response involving 
immune cells, blood vessels, and molecular mediators. The important function of 
inflammation is to eliminate the initial cause of cell injury, clear out the necrotic cells 
and tissues damaged from the original insult and the inflammatory process, and to 
initiate tissue repair. [12] 
CLASSICAL SIGNS OF INFLAMMATION 
Inflammation has been studied for thousands of years and Celsus in 30 A.D. 
described the four classical signs of inflammation [13] 
 Redness (rubor) 
An acutely inflamed tissue appears red, due to dilatation of small blood vessels 
within the damaged area (hyperemia). 
 Swelling (tumor) 
Swelling which occurs from edema is due to the accumulation of fluid in the 
extravascular space as part of the inflammatory fluid exudate, and to a much lesser 
extent, from the physical mass of the inflammatory cells migrating into the affected 
area. 
 Heat (calor) 
Increase in temperature is due to increased blood flow (hyperemia) through the 
region, resulting in vascular dilation and the delivery of warm blood to the area. 
 Pain (dolor) 
Pain results from the stretching partly and distortion of tissues due to inflammatory 
edema and, in part from some of the chemical mediators of acute inflammation, 
especially bradykinin and some prostaglandins.  
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 Loss of function (functiolaesa) 
Loss of function, a well-known consequence, which was added by Virchow (1821-
1902) to the list of features described in Celsus written work. Loss of function may 
occur from severe swelling that prevents movement in the area or from the pain that 
inhibits mobility. [14] 
CAUSES OF INFLAMMATION 
 Microbial infections: Microbes including viruses, bacteria, protozoa, fungi and 
various parasites.  
 Hypersensitivity reactions 
 Physical agents, irritant and corrosive chemicals: Physical trauma, ultraviolet 
or other ionizing radiation, burns or excessive cooling ('frostbite') may cause  
tissue damage leading to inflammation. Corrosive chemicals such as acids, 
alkalis, oxidizing agents are also inflammatory stimulus that can cause direct 
tissue damage. 
 Tissue necrosis: Lack of oxygen or nutrients results into inadequate blood flow 
and it is a potent inflammatory stimulus that can cause the death of tissues. [15][12] 
ROLE OF INFLAMMATION 
1. Physiological role of inflammation 
It can eliminate the cause of inflammation and thus helps to minimize 
tissue damage. It prevents the spreading of the cause of inflammation. 
Inflammation also helps to activate processes of regeneration and repair. 
Without inflammation, the tissues are not capable of healing. 
 
2. Pathological role 
It involves excessive or long-lasting reaction which leads to tissue 
damage. And also have role in pathogenesis of many diseases. [16] 
 
 
Introduction 
 
Department of Pharmacology  Page 7 
 
SYSTEMIC EFFECTS OF INFLAMMATION 
Both acute and chronic inflammation, even if well localized, can have effects 
on the whole body. The main ones are: 
 Leukocytosis  
Leukocytosis is a common feature and it is condition in which there is 
an abnormal increase in number of circulating white blood cells. A general rule 
is that increased neutrophils indicate a bacterial infection whereas increased 
lymphocytes are most likely to occur in viral infections. 
 Fever  
Fever is most often associated with inflammation that has an infectious 
cause, although there are some non-infectious febrile diseases. The elevation of 
body temperature is thought to improve the efficiency of leukocyte killing and 
may also impair the replication of many invading organisms. 
 Endotoxemia 
Sepsis is the term used for disease due to toxic bacterial products 
circulating in the blood. Endotoxemia specifically refers to circulating gram-
negative bacterial toxic products. There are some cell wall products released 
from gram-positive bacteria that can have a similar toxic effect. [15] 
TYPES OF INFLAMMATION 
By considering the defence capacity of the host and duration of response, 
inflammation can classified as; 
 Acute inflammation  
 Chronic inflammation 
Acute inflammation is of short duration, enduring less than 2 weeks and represents 
the early body reaction, resolves quickly and is usually followed by healing. 
The main features of acute inflammation are: 
 Accumulation of fluid and plasma at the affected site 
 Intravascular activation of platelets 
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 Polymorphonuclear neutrophils as inflammatory cells 
Chronic inflammation is of longer duration. The important feature of chronic 
inflammation is the presence of chronic inflammatory cells such as lymphocytes, 
plasma cells, macrophages, granulation tissue formation, and in specific situations as 
granulomatous inflammation. Chronic inflammation occurs either after the causative 
agent of acute inflammation persists for a long period of time, or the stimulus is such 
that it induces chronic inflammation from the beginning.  
ACUTE INFLAMMATION 
It can be divided into following two events: 
 Vascular events 
 Cellular events 
 VASCULAR EVENTS 
Vascular events comprise the alteration in the microvasculature (arterioles, 
capillaries and venules) and these alterations include 
o Haemodynamic changes 
o Changes in vascular permeability  
Haemodynamic Changes 
 Transient vasoconstriction of arterioles. The blood flow may be restored in 3-5 
seconds while with more severe injury the vasoconstriction may last for about 
5 minutes. 
 Persistent progressive vasodilatation is responsible for redness and warmth at 
the spot of acute inflammation. 
 Progressive vasodilatation, sequentially, may elevate the local hydrostatic 
pressure resulting in transudation of fluid into the extracellular space, 
responsible for swelling at the local site of acute inflammation. 
 Slowing or stasis of microcirculation follows which causes increased  
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concentration of red cells, and thus, raise the viscosity of blood. 
 Stasis is followed by leucocytic margination i.e. peripheral orientation of 
leucocytes (primarily neutrophils) along the vascular endothelium. The 
leucocytes attach to the vascular endothelium briefly, and then migrate through 
the gaps between the endothelial cells into the extravascular space.[17] 
Changes in vascular permeability 
In acute inflammation, the capillary hydrostatic pressure increases, and there is 
also escape of plasma proteins into the extravascular space due to increased vascular 
permeability (endothelial contraction allowing proteins to escape between cells). As a 
result, much more fluid leaves the vessels than is returned to them. The net escape of 
protein-rich fluid is called exudation and the protein rich fluid is called an exudate. 
The increase in vascular permeability in acute inflammation involves two mechanism 
 Chemical mediators of acute inflammation may cause retraction of endothelial 
cells leaving intercellular gaps (chemical mediated vascular leakage). 
 Toxins and physical agents may cause necrosis of vascular endothelium which 
may lead to an abnormal leakage (injury induced vascular leakage). 
In short vascular permeability increases due to endothelial contraction, retraction or 
injury mediated by leukocytes. [15]  
 CELLULAR EVENTS 
The cellular phase of inflammation consists of 2 processes: 
1) Exudation of leucocytes; and 
2) Phagocytosis 
Exudation of leucocyte 
Various leukocytes, mainly neutrophils, are critically involved in the initiation 
and maintenance of inflammation. These cells must be able to move to the site of injury 
from their usual location in the blood, therefore mechanisms exist to recruit and direct 
leukocytes to the appropriate place. The process of leukocyte movement from the blood  
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to the tissues through the blood vessels is known as extravasation, and can be broadly 
divided up into a number of steps: 
1. Leukocyte margination and endothelial adhesion:  
The white blood cells within the vessels which are generally centrally located 
move peripherally towards the walls of the vessels. Activated macrophages in the tissue 
release cytokines such as IL-1 and TNF α, which bind to their respective G protein- 
coupled receptors on the endothelial wall. Signal transduction induces the immediate 
expression of P-selectin on endothelial cell surfaces. This receptor binds weakly to 
carbohydrate ligands on the surface of leukocytes and causes them to "roll" along the 
endothelial surface as bonds are made and broken.  
Cytokines from injured cells prompt the expression of E-selectin on endothelial 
cells, which functions alike to P-selectin. Cytokines also induce the expression of 
integrin ligands such as ICAM-1 and VCAM-1 on endothelial cells, which facilitate 
the adhesion and further slow leukocytes down. These weakly bound leukocytes are 
free to separate if not activated by chemokines produced in injured tissue. Activation 
increases the affinity of bound integrin receptors for ICAM-1 and VCAM-1 on the 
endothelial cell surface, firmly binding the leukocytes to the endothelium. 
2. Migration across the endothelium via the process of diapedesis:  
It is known as transmigration. Chemokine gradients stimulate the adhered 
leukocytes to move between adjacent endothelial cells. Using adhesion molecules eg. 
ICAM-1 the endothelial cells retract and the leukocytes pass through the basement 
membrane into the surrounding tissue. 
3. Movement of leukocytes within the tissue via chemotaxis:  
Leukocytes reaching the tissue interstitium bind to extracellular matrix proteins 
through expressed integrins and CD44 to prevent them from leaving the site. A variety 
of molecules behave as chemoattractants. For e.g. potent chemotactic substances for 
neutrophils are leukotriene B4, cytokines, soluble bacterial products, components of 
complement system. 
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Phagocytosis 
Phagocytosis is defined as the process of engulfment of solid particulate material 
by the cells (cell-eating). The cells performing this function are called phagocytes. 
There are 2 main types of phagocytic cells: 
 
i. Polymorphonuclear neutrophils (PMNs), sometimes called microphages which 
appears early in acute inflammatory response 
ii. Circulating monocytes and fixed tissue mononuclear phagocytes, commonly 
called as macrophages. 
Neutrophils and macrophages on reaching the tissue spaces produce several 
proteolytic enzymes—lysozyme, protease, collagenase, elastase, lipase, proteinase, 
gelatinase, and acid hydrolases. These enzymes degrade collagen and extracellular 
matrix. The microbe undergoes the process of phagocytosis by polymorphs and 
macrophages and involves the following 3 steps: 
a) Recognition and attachment 
b) Engulfment 
c) Killing and degradation 
Recognition and attachment 
By the expression of surface receptors on macrophages which recognise 
microorganisms: mannose receptor and scavenger receptor phagocytosis is initiated. 
When the microorganisms are coated with specific proteins, opsonins, from the serum 
or they get opsonised the process of phagocytosis is further improved. Opsonins create 
a bond between the cell membrane of phagocytic cell and bacteria. The major opsonins 
present in the serum and their matching receptors on the surface of phagocytic cells 
(PMNs or macrophages) are as under: 
 IgG opsonins the Fc fragment of immunoglobulin G; it is the naturally occurring 
antibody in the serum that coats the bacteria while the PMNs possess receptors 
for the same. 
 C3b opsonins the fragment produce by activation of complement pathway. It is 
strongly chemotactic for attracting PMNs to bacteria. 
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 Lectins are carbohydrate-binding proteins in the plasma which bind to bacterial 
cell wall. 
Engulfment  
The opsonised particle bound to the surface of phagocyte is equipped to be 
engulfed. This is accomplished by development of cytoplasmic pseudopods around the 
particle due to activation of actin filaments under cell wall, enveloping it in a 
phagocytic vacuole. Eventually, the plasma membrane enclosing the particle breaks 
from the cell surface so that membrane lined phagocytic vacuole or phagosome lies 
internalised and free in the cell cytoplasm. The phagosome fuses with one or more 
lysosomes of the cell and form larger vacuole called phagolysosome. 
Killing and degradation 
It is the stage of killing and degradation of microorganism to dispose it off 
justifying the function of phagocytes as scavenger cells. The microorganisms after 
being killed by antibacterial substances are degraded by hydrolytic enzymes. However, 
this mechanism fails to kill and degrade some bacteria like tubercle bacilli. [17[[18] 
CHEMICAL MEDIATORS OF INFLAMMATION [18] 
1. Plasma derived  
2. Cell derived 
Table 1: Plasma-derived mediators 
  
Name Produced 
by 
Description 
 
Membrane 
attack 
complex 
 
Complement 
system 
A complex of the complement 
proteins C5b, C6, C7, C8, and multiple units of C9. The 
combination and activation of this range of complement 
proteins forms the membrane attack complex, which is 
able to introduce into bacterial cell walls and causes cell 
lysis resulting bacterial death. 
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Plasmin 
Fibrinolysis 
system 
Able to break down fibrin clots. Also plasmin cleaves the 
complement protein C3, and activate Factor XII. 
 
Thrombin 
 
Coagulation 
system 
Thrombin cleaves the soluble plasma 
protein fibrinogen to produce insoluble fibrin. Fibrin 
then aggregates to form a blood clot. Through PAR1 
receptor thrombin can bind to cells to trigger several 
other inflammatory responses, such as production 
of chemokines and nitric oxide. 
Factor XII 
(Hageman 
Factor) 
Liver It is a protein that circulates inactively. But get activated 
by collagen, platelets, or exposed basement 
membranes via conformational change. On activation it 
is able to activate three plasma systems involved in 
inflammation: the kinin system, fibrinolysis system, and 
coagulation system. 
 
Bradykinin 
 
Kinin 
system 
Bradykinin cause vasodilation, increase vascular 
permeability, smooth muscle contraction, and also pain. 
Bradykinin is a vasoactive protein. 
 
 
C3 
 
 
Complement 
system 
C3 Cleaves to produce C3a and C3b. C3a can produce 
the histamine release by mast cells and thereby produce 
vasodilation. C3b can bind to bacterial cell walls and act 
as an opsonin as a target for phagocytosis. 
 
C5a 
 
Complement 
system 
Stimulates histamine release by mast cells. Histamine 
can produce vasodilation. Through chemotaxis it is also 
able to act as a chemoattractant to direct cells to the site 
of inflammation. 
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Table 2: Cell-derived mediators 
 
 
Name Type Source Description 
 
 
Lysosome 
granules 
 
 
Enzymes 
 
 
Granulocytes 
Contains a large variety of enzymes that 
perform a number of functions and are 
able to break down a number of 
substances, some of which may be 
plasma-derived proteins that allow these 
enzymes to act as inflammatory 
mediators. 
 
 
Histamine 
 
 
Monoamine 
 
 
Mast cells 
and basophils 
Stored in preformed granules, histamine 
is released in response to a number of 
stimuli. It causes arteriole dilation, 
increased venous permeability, and a 
wide variety of organ-specific effects. 
 
 
IFN-γ 
 
 
Cytokine 
 
 
T-cells, NK 
cells 
This interferon called macrophage-
activating factor, and is especially 
important in the maintenance of chronic 
inflammation. Also have antiviral, 
immunoregulatory, and anti-tumour 
properties. 
 
IL-8 
 
Chemokine 
 
Primarily 
macrophages 
Activation and chemoattraction of 
neutrophils. Have weak effect on 
monocytes and eosinophils. 
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Leukotriene 
B4 
 
 
 
 
Eicosanoid 
 
 
 
 
Leukocytes, 
cancer cells 
Have the ability to mediate leukocyte 
adhesion and activation. And allow 
them to bind to the endothelium and 
migrate across it. In neutrophils, it is 
also a chemoattractant. And it is able to 
induce the formation of reactive 
oxygen species, followed by the release 
of lysosomal enzymes by these cells. 
 
 
 
 
 
IL-1 and 
TNF-α 
 
 
 
 
 
Cytokines 
 
 
 
 
 
Primarily 
macrophages 
IL-1 and TNF-α induce many similar 
inflammatory reactions such as fever, 
production of cytokines, endothelial 
gene regulation, chemotaxis, leukocyte 
adherence, activation of fibroblasts. 
Also responsible for the systemic 
effects of inflammation, such as loss of 
appetite and increased heart rate. In 
additionally TNF-α inhibits osteoblast 
differentiation. 
 
 
 
LTC4, LTD
4 
 
 
 
Eicosanoid 
 
 
 
Eosinophils, 
mast cells,  
macrophages 
These three Cysteine-containing 
leukotrienes contract lung airways, 
increase micro-vascular permeability, 
stimulate mucus secretion, and promote 
eosinophil-based inflammation in the 
lung, skin, nose, eye, and other tissues. 
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5-oxo-
eicosatetraenoi
c acid 
 
 
 
Eicosanoid 
 
 
 
leukocytes, 
cancer cells 
 
Potent stimulator of neutrophil 
chemotaxis, lysosome enzyme 
release, and ROS formation; 
monocyte chemotaxis; and with even 
greater potency eosinophil. 
 
 
 
 
5-HETE 
 
 
 
 
Eicosanoid 
 
 
 
 
Leukocytes 
 
Metabolic precursor to 5-oxo-
eicosatetraenoic acid, it is a less 
potent stimulator of neutrophil 
chemotaxis, lysosome enzyme 
release, and reactive oxygen species 
formation; monocyte chemotaxis; 
and eosinophil chemotaxis, 
lysosome enzyme release, and 
reactive oxygen species formation. 
Prostaglandins Eicosanoid Mast cells A group of lipids that can cause 
vasodilation, fever, and pain. 
Nitric oxide Soluble gas Macrophage,  
endothelial 
cells, some 
neurons 
Potent vasodilator, relaxes smooth 
muscle, reduces platelet aggregation, 
aids in leukocyte recruitment, direct 
antimicrobial activity in high 
concentrations. 
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THE INFLAMMATORY CELLS 
The cells involved in acute and chronic inflammation are circulating leukocytes, 
plasma cells and tissue macrophages. 
 Polymorphonuclear neutrophils are acute inflammatory cells, which are 
involved in initial phagocytosis of bacteria and foreign bodies, engulfment of 
antigen-antibody complexes. 
 Monocytes are chronic inflammatory cells which are involved in bacterial 
phagocytosis and regulates lymphocyte response. 
 Lymphocytes are chronic inflammatory cells which are involved in humoral 
and cell mediated immune responses and regulate macrophage responses. 
 Eosinophils are chronic inflammatory cells which are involved during allergic 
states and parasitic infestations. 
 Basophils containing electron dense molecules and functions as receptor for Ig 
E molecules 
 Plasma cells are derived from B cells and it is larger than lymphocytes with 
more abundant cytoplasm and eccentric nucleus. Their number increased during 
prolonged infection with immunological responses, hypersensitivity states and 
multiple myeloma. 
 Giant cells exist in normal tissues. In chronic inflammation when macrophages 
fail to deal with particles to be removed, they fused together and form 
multinucleated giant cells. Besides, morphologically distinct giant cells appear 
in some tumours also. [17] 
CHRONIC INFLAMMATION 
Chronic inflammation, is a host response to an inciting stimulus. Chronic 
inflammation is characterized by inflammation, tissue destruction, and attempts at 
repair all happening at once. Inflammation does not have as much rubor (redness) or 
calor (heat) as in the acute reaction. Also, exudates aren’t so grossly apparent as in 
acute inflammation. Because of the fibroplasia and neovascularization, areas affected  
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by chronic inflammation tend to be slightly swollen and firm. If fibrosis is extensive 
the lesions can be large and disfiguring. Fibrosis (granulation tissue) is the best 
indicator that the inflammatory response is chronic. [15] 
Chronic inflammation have prolonged duration. Chronic inflammation in 
contrast to acute inflammation is characterised by the vascular changes, edema and a 
predominantly neutrophilic infiltrate. Chronic inflammation is distinguished by  
 Infiltration with mononuclear cells which includes macrophages, lymphocytes 
and plasma cells  
 Tissue destruction, largely induced by the products of the inflammatory cells. 
 Repairing which involves new vessel proliferation (angiogenesis) and fibrosis.  
Acute inflammation may progress to chronic inflammation. This change occurs 
when the acute response cannot be resolved, either because of the persistence of the 
inflammatory agent or because of the intervention with the normal process of healing.  
Chronic inflammation can be caused by one of the following 3 ways: 
o Recurrent attacks of acute inflammation : In recurrent urinary tract infection 
leading to chronic pyelonephritis 
o Chronic inflammation following acute inflammation: It occurs when tissue 
destruction is extensive, or the bacteria survive and persist in small numbers at 
the site of acute inflammation chronic inflammation may occurs. E.g. for such 
situation is osteomyelitis, pneumonia terminating in lung abscess.   
o Chronic inflammation starting de novo: e.g. infection with Mycobacterium 
tuberculosis  
TYPES OF CHRONIC INFLAMMATION  
 Non-specific inflammation, occurs when the irritant substances causes an 
inflammatory reaction with the formation of granulation tissue and healing by 
fibrosis e.g. chronic osteomyelitis, chronic ulcer.  
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 Specific, when the injurious agent causes a characteristic histologic tissue 
response e.g. tuberculosis, leprosy.  
According to histopathological changes chronic inflammation can be classified as:  
 Chronic non-specific inflammation: It is characterised by non-specific 
inflammatory cell infiltration e.g. chronic osteomyelitis, lung abscess. An 
alternative of this type is chronic suppurative inflammation. This type of 
inflammation is characterised by infiltration of polymorphs and abscess 
formation additionally. e.g. actinomycosis. 
 Chronic granulomatous inflammation: Important feature is the formation of 
granulomas e.g. tuberculosis, leprosy, syphilis etc.  
GRANULOMATOUS INFLAMMATION 
Chronic inflammation characterised by the aggregates of activated 
macrophages that assume an epithelioid appearance.  
The causes of or conditions in which granuloma develops are  
 Bacterial infections 
 Fungal infections  
 Parasites  
 Foreign bodies 
 Immune conditions  [19] 
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PATHOGENESIS OF GRANULOMA FORMATION 
Figure 1: Pathogenesis of granuloma formation 
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FEVER 
Fever is also known as pyrexia or febrile response. It is defined as the elevation 
of temperature in the preoptic zone of frontal area of hypothalamus above thermal set 
point of 37 0C. A fever can be an only symptom in variety of medical conditions and it 
may be due to viral, bacterial & parasitic infections, systemic conditions, side effects 
of medication and even cancer. About 30% children and 75% adults visit the healthcare 
centres for the fever. [20] 
RANGE FOR NORMAL TEMPERATURES 
A wide range for normal temperatures are found. Central temperatures, such as 
rectal temperatures, are much more precise than peripheral temperatures. Fever is 
mostly agreed to be present if the elevated temperature is caused by a raised set point 
and: 
 Temperature in the anus (rectum/rectal) is at or over 37.5–38.3 °C  
(99.5–100.9 °F) 
 Temperature in the mouth (oral) is at or over 37.7 °C (99.9 °F) 
 Temperature under the arm (axillary) or in the ear (tympanic) is at or over  
37.2 °C (99.0 °F) 
Table 3: Temperature classification  
Type Temperature 
Hypothermia < 35.0 0C (95.0 0F) 
Normal 36.5 – 37.5 0C (97.7-99.5 0F) 
Fever >37.5 or 38.3 0C (99.5 or 100.9 0F) 
Hyperthermia 37.5 or 38.3 0C (99.5 or 100.9 0F) 
Hyperpyrexia 40.0 or 41.0 0C (104.0 or 105.8 0F) 
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HYPERPYREXIA  
It is an extreme elevation of body temperature. Hence it is considered as a 
medical emergency condition. It may indicate a serious underlying condition or lead to 
problems including permanent brain damage, or death. The most common cause of 
hyperpyrexia is an intracranial hemorrhage. Other possible causes include Kawasaki 
syndrome, sepsis, neuroleptic malignant syndrome, drug overdose, serotonin 
syndrome, and thyroid storm. 
HYPERTHERMIA  
It is an example of a high temperature. It   is not a fever. It occurs due to several 
causes including heatstroke, neuroleptic malignant syndrome, malignant hyperthermia, 
stimulants such as substituted amphetamines and cocaine, idiosyncratic drug reactions, 
and serotonin syndrome. 
Infections are the most important cause of fevers. Infections generally related 
with hyperpyrexia consist of roseola, measles and enteroviral infections. Immediate 
aggressive cooling to less than 38.9 °C (102.0 °F) has been found to improve survival. 
Hyperpyrexia and hyperthermia are different wherein, in hyperpyrexia the body's 
temperature regulation mechanism sets the body temperature above the normal 
temperature. Then inorder to attain the normal body temperature, heat is produced while 
in hyperthermia due to an external source the body temperature rises above its set point. 
TYPES OF FEVER 
1. Continuous fever: Throughout the day the temperature remains above normal 
and does not fluctuate more than 1 °C in 24 hours. 
2. Intermittent fever: The temperature elevation is present only for a certain 
period, after that cycling back to normal. 
3. Remittent fever: Throughout the day the temperature remains above normal and 
in 24 hours temperature fluctuates more than 1 °C. 
4. Pel-Ebstein fever: A specific kind of fever associated with Hodgkin's 
lymphoma, being high for one week and low for the next week and so on.[21] 
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GENESIS OF FEVER 
Inflammatory mediators (i.e., cytokines, namely interleukin-1, interleukin-6, 
tumor necrosis factor, and others) that are predominantly released by activated 
peripheral mononuclear phagocytes and other immune cells. [22] 
PYROGENS 
 A pyrogen is a substance that induces fever. They are two types. Endogenous and 
exogenous pyrogens. 
 Endogenous pyrogens 
All endogenous pyrogens are cytokines. Cytokines are the molecules that are a 
part of the immune system and are produced by activated immune cells. It causes the 
increase in the thermoregulatory set point in the hypothalamus. Interleukin 1 (α and β) 
and interleukin 6 (IL-6) are major endogenous pyrogen. While interleukin-8, tumor 
necrosis factor-β, macrophage inflammatory protein-α and macrophage inflammatory 
protein-β as well as interferon-α, interferon-β, and interferon-γ are the minor 
endogenous pyrogens. Tumor necrosis factor-α also acts as a pyrogen. It is mediated 
by interleukin 1 (IL-1) release. 
 Exogenous pyrogens 
LPS is a cell wall component of gram-negative bacteria. Lipopolysaccharide-
binding protein (LBP) is an immunological protein which binds to LPS. The LBP–LPS 
complex binds to the CD14 receptor of a nearby macrophage. The synthesis and release 
of various endogenous cytokine factors, such as interleukin 1 (IL-1), interleukin 6 (IL-
6), and the tumor necrosis factor-α occurs after the binding to CD14 receptor. Thus the 
exogenous factors can cause release of endogenous factors, which in turn, initiate the 
arachidonic acid pathway. Through the inhibition of ATP production by mitochondria, 
the highly toxic metabolism-boosting supplement 2, 4 -Dinitrophenol induces 
[hyperthermia] high body temperature. Instead of producing ATP, the energy of the 
proton gradient is lost as heat. [21] 
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PATHOPHYSIOLOGY OF FEVER 
 Fever is recognized as a complex, coordinated, autonomic, behavioral response 
and neuroendocrine which occurs due to acute phase reaction to immune challenge. [23] 
Natural defence system of the human body is activated whenever body finds any 
infectious agent in order to create an unfavourable environment for the survival of 
infectious agent. The infectious agent or damaged tissues initiate the increase 
production of proinflammatory mediators cytokines such as interleukin 1β, β, α and 
TNF-α which enhance the formation of prostaglandin E2 (PGE2) near the peptic 
hypothalamus area and the prostaglandin in turn act on the hypothalamus to elevate the 
body temperature. [24] 
A centre in the hypothalamus controls the balance between heat loss and heat 
production that regulates normal body temperature. Fever occurs due to this disturbance 
of hypothalamic ‘thermostat’, which leads to the set point of body temperature being 
raised. [25] 
 
Figure 2: Pathophysiology of fever 
So whenever the body temperature becomes high, blood vessels dilated and 
sweating increases to reduce the high temperature. But when the body temperature is 
low then vasoconstriction occurs to protect the internal body temperature. Increase 
temperature as in case of fever leads to faster disease progression due to increased tissue 
catabolism, dehydration and persisting complaints as in case of HIV infection and other 
chronic infections. [24] 
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MOLECULAR MECHANISM OF FEVER 
 Distinct members of Toll receptors in macrophages receptor family recognize 
different and specific microbial components, but biosynthesis and releases same 
endogenous pyrogens, such as IL-1β, TNF, and IL-6. [23] 
Cytokines which are transported by the bloodstream could act at sites lacking a 
tight blood–brain barrier, the so-called circumventricular organs. Alternatively, 
circulating cytokines could interact with their specific receptors on brain endothelial 
cells or perivascular cells and thereby stimulate these cells to release pyrogenic 
mediators into the abluminal brain tissue. It has been proposed that fever-promoting 
cytokines are transported from the blood into the brain via specific carriers. An assumed 
manifestation of a febrile response produced by these mechanisms is termed as the 
humoral hypothesis of fever induction. [22] 
These pyrogenic cytokines acts on organum vasculosum area of the brain 
known as laminae terminalis leading to activation of the enzyme cyclo-oxygenase-2 
(COX-2) that results in release of prostaglandin E2 (PGE2), which binds to receptors in 
the hypothalamus leading to an increase in heat production and a decrease in heat loss 
until the temperature in the hypothalamus reaches an elevated set-point. [23] 
Figure 3: Molecular mechanism of fever 
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HOME REMEDIES FOR TREATMENT OF FEVER 
When there is mild fever home remedy is sufficient to treat it, mainly when 
there is mild infection like flu and cold. Some of the remedies are, 
 Fluid intake should be increased. 
 If the fever is high then bath to reduce it and not to eliminate it, room should be 
well ventilated. 
 If the fever raises continuously then sponging with lukewarm water can be 
useful. 
 Any type of stress should be avoided. 
 Herbs and other cooking ingredient are also used to reduce fever. 
 Boiled filtrate of basil leaves in water on drinking once a day reduces 
temperature. 
 When fever is present then half teaspoon of saffron is taken with warm water. 
 Grape fruit juice with water is useful in reducing fever. 
 Honey mixed with ginger is useful in fighting fever. [23] 
ALLOPATHIC TREATMENT OF FEVER 
For treatment of fever it is necessary to know the fever’s underlying cause. 
Different over the counter are used in reducing body temperature to a normal level as 
well as to treat the underlying cause. OTC antipyretic that are used normally includes 
nonsteroidal anti-inflammatory drugs like aspirin, nimesulide, paracetamol, 
ketoprofen, ibuprofen, meloxicam, celecoxib, rofecoxib etc.  
TARGET OF ANTIPYRETIC DRUG 
Cyclooxygenase (COX) enzyme is also known as prostaglandin endoperoxide 
synthase, and it is the key enzyme required for the synthesis of prostaglandins from 
arachidonic acid. Two COX isoforms that have been identified are COX-1 and COX-
2. In many situations, the COX-1 enzyme is produced constitutively whereas COX-2 
is highly inducible. Nonsteroidal anti-inflammatory drugs inhibit both COX-1 and 
COX-2 enzymes, while a new class of COX-2 selective inhibitors preferentially inhibits 
the COX-2 enzyme only. [23] 
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The elevated body temperature is reduced by antipyretic drugs which inhibit 
COX-2 expression thereby inhibiting prostaglandin synthesis. However these synthetic 
antipyretic agents inhibit the COX-2 with high selectivity but they have toxic effects 
on other organs like glomeruli, cortex of the brain, hepatic cells and heart muscles. [24] 
 
Table 4: Adverse effect associated with NSAID Therapy [26] 
System Adverse effect 
Gastrointestinal  Peptic ulcer 
Esophagitis and strictures 
Small and large bowel erosions 
Renal  Reversible acute failure 
Chronic renal failure 
Interstitial nephritis 
Nephrotic syndrome 
Fluid and electrolyte disturbances 
 
Cardiovascular 
Exacerbation of hypertension 
Exacerbation of congestive cardiac 
failure 
Exacerbation of angina 
Hepatic Elevated transaminases 
Fulminant hepatic failure (rare) 
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CNS Headache 
Drowsiness 
Confusion and behaviour disturbance 
Aseptic meningitis 
Hematological Thrombocytopenia 
Hemolytic anaemia 
Agranulocytosis and aplastic anaemia 
Other Exacerbation of asthma and nasal 
polyposis, Rash 
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2. REVIEW OF LITERATURE 
 
 Rafik U. Shaikh et al., (2016) investigated in vivo and in vitro anti-inflammatory 
potential of the extracted plant samples of Cissus quadrangularis, Plumbago 
zeylanica, Terminalia bellarica and Terminalia chebulla in water, ethanol and 
hexane. These were evaluated in-vitro for COX-1 and 2 inhibitory and antioxidant 
activities. Carrageenan model and Phorbol Myristate acetate induced mice edema 
model were used for the evaluation of in vivo anti-inflammatory activity. 
Indomethacin (20 mg/kg, p.o) was used as standard drug for carrageenan induced 
inflammation. Phorbol Myristate Acetate induced mice edema model was done by 
using indomethacin (2 mg per ear in 20 ml acetone) as standard. The results 
obtained revealed that most of the plants were found to inhibit COX-2 activity as 
compared to COX-1. The ethanolic extract showed effective DPPH, hydroxyl and 
superoxide radical scavenging activity. In vivo anti-inflammatory study shows that, 
Terminalia bellarica and Terminalia chebulla had a significant impact on 
inhibition of edema formation.[27] 
 
 Anum khan et al., (2015) evaluated antimicrobial, anti-inflammatory and 
antipyretic activity of Chorisia speciosa leaves. Antipyretic and anti-inflammatory 
activities of plant were determined by using Wistar albino rats. Rats were tested 
with doses of 200 and 400 mg/kg body weight (p.o). Antibacterial and antifungal 
activity of Chorisia speciosa were evaluated by disc diffusion method. Significant 
antibacterial activity was shown against Bacillus cereus, Staphylococcus aureus, 
Klebsiella pneumoniae and Pseudomonas aeruginosa, while methanol extract of 
C.speciosa showed noticeable zone of inhibition (11 mm) against fungal Candida 
albicans strain. In Carrageenan-induced rat hind paw oedema, inflammation was 
significantly antagonized by extracts of Chorisia speciosa at 400 mg/kg. 
Diclofenac sodium (10 mg/kg) was used as standard. In brewer’s yeast induced 
pyrexia chloroform extract of Chorisia speciosa demonstrated dose dependently 
protection which is comparable to standard drug paracetamol (150 mg/kg). [28] 
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 Vinodhini Velu et al., (2015) aimed to assess the phytochemical analysis, in vitro 
anti-arthritic activity and hemolytic activity of the petroleum ether, chloroform, 
ethyl acetate and aqueous extracts of Tragia involucrate. The phytochemical 
analysis revealed the presence of phytoconstituents such as phenols, flavonoids, 
sterols and terpenoids etc. The maximum inhibition of anti-arthritic activity by 
protein denaturation inhibition assay was observed in chloroform extract at the 
concentration of 200 μg/ml. And the extracts was also found to be non-hemolytic 
against the red blood cell membranes. [29] 
 
 Dr. S. Chitra et al., (2015) studied the anti-inflammatory activity of 
Kandangkathiri Kirutham at the dose of 100 mg/kg and 200 mg/kg. Anti-
inflammatory activity was evaluated by Carrageenan-induced paw edema in rats 
using Diclofenac sodium as the standard drug (50 mg/kg). Treatment with 
Kandangkathiri Kirutham at the dose of 100 mg/kg shown displacement value 
ranges from 0.331 to 1.287 ml. Treatment at the dose of 200 mg/kg shown 
displacement value ranges from 0.355 to 1.237 ml. Treatment with standard drug 
Diclofenac at the dose of drug at 50 mg/kg shown displacement value ranges from 
0.325 to 1.168 ml. From the result, it was concluded that test sample significantly 
reduced the paw edema induced by carrageenan at both the dose level. [30] 
 
 Mohammad Asim Khan et al., (2015) conducted the antipyretic study on crude 
(600 mg/kg and 1200 mg/kg) and aqueous extract (162 mg/kg and 324 mg/kg) of 
Gule Ghaafis on yeast induced pyrexia in animal model. The crude form of Gule 
Ghaafis showed significant reduction in fever in higher dose and the extract of Gule 
Ghaafis in both lower and higher dose reduced fever by inhibition of the production 
of prostaglandins. [31] 
 
 Anitha John et al., (2015) investigated Kabasura kudineer choornam by analytical 
methods and chromatographic studies with a view to suggest standards for 
evaluating its quality and purity. The choornam was subjected to physico-chemical 
analysis, preliminary phytochemical analysis, TLC and HPTLC studies. The 
preliminary phytochemical investigations of choornam showed the presence of  
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major secondary metabolites which reveals the potent therapeutic activity. TLC 
and HPTLC study indicated that the chemical constituents are present in significant 
quantity in the crude extract. [10] 
 
 Thillaivanan. S et al., (2015) reviewed the ethno pharmacological activities of the 
ingredients of Kabasura kudineer choornam to strengthen the scientific facts 
favoring this formulation. The phyto chemical constituents and pharmacological 
actions of the ingredients present in the formulation have anti-inflammatory, 
antipyretic, analgesic, anti-viral, anti-bacterial, anti-fungal, anti-oxidant, hepato 
protective, anti-diabetic, anti-asthmatic, anti-tussive, immunomodulatory, anti-
diarrhoeal and anti-oxidant activities. Based on the survey the choornam can be 
used for preventative as well as curative for swine flu. [11] 
 
 T. Chandrasekar et al. (2015), studied the medicinal efficacy of Nimbadipatra 
choornam by undertaking phytochemical analysis, antimicrobial activity effect, 
antioxidant effect and GC MS analysis. The phytochemicals present in choornam 
were saponins, tannins, triterpenoids, cardiac glycosides, phytosterol, coumarin 
and phenolic compounds. Strong antimicrobial activity of this medicine was 
observed against the microorganisms such as Klebsiella pneumoniae, 
Staphylococcus aureus, Escherichia coli and Candida albicans. The potential of 
the choornam to serve as antioxidants were assayed by reducing power assay, 
peroxidase assay and catalase assay. The results of antibacterial, antifungal, 
antioxidant and GC MS analysis clearly indicate that the components present in 
choornam have important properties such as anti-viral, antibacterial, antifungal, 
antioxidant, anti-inflammatory etc. [32] 
 
 Ranveera Chathuranga Barathee et al., (2014) evaluated in vitro antiarthritic 
activity of aqueous root extract of Clitoria ternatea by using an in vitro bioassay 
model i.e. inhibition of heat induced denaturation of albumin protein. The 
antidenaturation action of aqueous root extract was found comparable to the 
reference drug Diclofenac sodium. From the observations it was concluded that the 
aqueous root extract of Clitoria ternatea possesses anti-arthritic activity. [33] 
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 Ngoci Njeru S., (2014) screened for the antibacterial activity of methanolic root 
extract of Cissampelos pareira L. by disc diffusion method. The highest inhibition 
was demonstrated toward Staphylococcus aureus (20 mm), Pseudomonas 
aeuroginosa (17 mm), Klebsiella pneumoniae (14 mm) and Escherichia coli at (9 
mm). Proteus vulgaris and Streptococcus pneumoniae were not sensitive to the 
extract at all. The phytochemical screening demonstrated the presence of alkaloids, 
flavonoids, tannins, terpenoids and steroids. [34] 
 
 Evan Prince Sabina et al., (2013) evaluated the analgesic, antipyretic and 
ulcerogenic effects of piperine, which is an active ingredient of pepper. Mice were 
administered piperine (20 and 30 mg/kg) intraperitoneally. The analgesic activity 
of piperine were investigated by hot plate reaction test and acetic acid test. 
Antipyretic activity was determined by brewer’s yeast induced hyperpyrexia 
model. It was found that piperine exhibits significant analgesic and antipyretic 
activities without any ulcerogenic effects. The results were comparable with 
indomethacin (10 mg/kg) which was used as standard drug for reference. [35] 
 
 Ismail Shareef. M et al., (2013) evaluated the anti-rheumatic properties of 
methanolic extracts of the aerial parts and roots of the plant Clerodendrum 
serratum L. (200 mg/Kg and 400 mg/Kg). The activity of the methanolic extracts 
was studied based on the effects of carrageenan-induced rat paw oedema by using 
the standard drug indomethacin (10 mg/Kg). The methanolic extracts of aerial parts 
and roots of Clerodendrum serratum L. produced significant anti-rheumatic 
activity in a dose-dependent manner. [36] 
 
 Sahaya Sathish S et al., (2013) investigated the antimicrobial activity of stem and 
leaf extract of Tragia involucrata L. Activity was determined against 7 pathogenic 
bacteria and fungi by disc diffusion method. The chloroform stem extract and 
ethanol leaf extract showed higher inhibition in bacterias like Pseudomonas 
aeruginosa and Vibrio cholerae. Ethanol and methanol stem extract has more 
effect against fungi like Aspergillus niger and Rhizopus arrhizus. There was no 
activity against Penicillium chrysogenum. [37] 
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 Indira Priya Darsini et al.,(2013) investigated the antibacterial properties of 
organic solvent (Ethanol, Methanol, Hexane) and water extracts of the whole plant 
of Clitoria ternatea against Salmonella typhimurium, Proteus vulagaris, Shigella 
dysenteriae and a fungal pathogen Candida albicans by agar disc diffusion method. 
Antibacterial activity was found to be more in methanolic extract. While others 
also proven antimicrobial activity. [38] 
 
 Bairagi Shripad M. et al., (2012) investigated for the analgesic and anti-
inflammatory activities of Ficus microcarpa L. leaves extract in animal models. 
The extract at 50, 100 and 200 mg/kg reduced significantly the formation of 
oedema induced by carrageenan and histamine. In the acetic acid-induced writhing 
model, the extract showed a good analgesic effect characterized by a reduction in 
the number of writhes when compared to the control. Similarly, the extract caused 
dose-dependent decrease of licking time and licking frequency in rats injected with 
2.5% formalin. These results were also comparable to those of diclofenac sodium 
(20 mg/kg), the reference drug used in this study. [39] 
 
 Agbaje E. O. et al., (2012) explored the anti-inflammatory potential of aqueous 
root extract of Strophanthus hispidus in rodents. Doses of 50, 100, 500 and 1000 
mg/kg of aqueous extract were administered orally in carrageenan-induced hind 
paw oedema in rat, xylene induced ear oedema, and formalin-induced hind paw 
oedema in mice, using indomethacin (10 mg/kg), dexamethasone 1 mg/kg and 
acetylsalicylic acid 100 mg/kg respectively as standard drugs. Finally the results 
obtained showed that the extract exerted a dose-dependent and significant anti-
inflammatory activity, which compared favourably with the positive control. [40] 
 
 Vasu Kandati et al., (2012) evaluated the analgesic and anti-inflammatory activity 
of both chloroformic and methanolic root extracts of Andrographis serpyllifolia. 
Chloroform and methanolic root extracts showed moderate potency in inhibiting 
5-LOX. However, in-vivo anti-inflammatory studies revealed that methanolic 
extract has shown higher degree of efficacy when compared to the chloroformic  
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extract. In terms of analgesic activity, methanolic extract showed more efficacy 
than chloroformic extract. [41] 
 
 Anupama A Suralkar et al., (2012) investigated the effects of methanolic extract 
of Tamarindus indica seeds on anti-inflammatory and analgesic activities in vivo 
using rat as an animal model at the doses of 100 mg/kg, 200 mg/kg and 400 mg/kg 
body weight. The anti-inflammatory activities were investigated by utilizing 
carrageenan induced paw edema and the analgesic activity by tail immersion 
method in rats. The results showed that Tamarindus indica significantly reduced 
carrageenan induced paw edema in rats. In tail immersion method, extract showed 
significant increase in reaction time of tail in water maintained at 55°C indicating 
analgesic activity.[3] 
 
 Hemayet Hossain et al., (2012) determined total flavonoids, tannin contents and 
performed anti-inflammatory activity of ethanolic root extract of Lagenaria 
siceraria at different doses (200 and 400 mg/kg). The percentage inhibition of the 
oedema paw volume by the 400 mg/kg body weight of the extract was statistically 
significant compared favorably with the indomethacin (10 mg/kg) treated animals 
at 1, 2 and 3 h in both carrageenan and histamine models. The total flavonoids and 
tannins content were calculated as quite high in ethanolic extract. [42] 
  
 Naveed Muhammad et al., (2012) investigated antipyretic, analgesic and anti-
inflammatory activity of Viola betonicifolia whole plant. In yeast induced pyrexia, 
plant demonstrated dose dependently (78.23%) protection at 300mg/kg, similar to 
standard drug, paracetamol (90%) at 150 mg/kg i.p. plant also showed a dose 
dependent analgesia in various pain models i.e. acetic acid, hot plat and tail 
immersion at 300 mg/kg. Similarly carrageenan and histamine induces 
inflammation was significantly antagonized by plant, 66.30% and 60.80% 
respectively at 300mg/kg. Diclofenac (10 mg/kg) was used as standard for both 
study.[43] 
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 Anbarasu K et al., (2011) tested the antipyretic, anti-inflammatory and analgesic 
activity of ethanolic extract of nilavembu kudineer choornam (EENKC) to support 
its actions. In brewer’s yeast induced pyrexia and carrageenan-induced 
inflammation, extract at the doses of 200 and 400 mg/kg inhibited fever and 
inflammation significantly compared to control groups. In mice, the number of 
writhing induced by acetic-acid was significantly reduced after treatment with both 
the dose of aqueous extract than control animals. And proved that choornam had 
antipyretic, anti-inflammatory, and analgesic activity. [44] 
 
 Paval et al., (2011) demonstrate the antiarthritic activity of ethanol extract of 
Tinospora cordifolia. Arthritis was induced in Wistar rats using Freund’s complete 
adjuvant and Bovine type II collagen. Various haematological parameters used to 
assess the effectiveness of the treatment. These were supported by histological 
study of the affected ankle joints using haematoxylin and eosin. Results suggested 
that oral dosage of 150 mg/kg body weight exhibited anti-arthritic activity in 
Freund’s adjuvants arthritic rats. In collagen induced arthritic rats, the dosage of 
100 mg/kg body weight showed anti-arthritic activity. [45] 
 
 Uma Chandur et al., (2011) evaluated the presence of chemically active 
compounds of the petroleum ether, chloroform, and alcoholic extracts of the 
Saussurea lappa roots by standard methods and screened for their antiarthritic 
activity by using Complete Freund’s Adjuvant (CFA) induced rat model. 
Application of all the three extracts exhibited significant edema inhibition when 
compared with the arthritic control group. The application of standard piroxicam 
gel was found to inhibit this edema to an extent of 66.96 %. The test extracts 
petroleum ether, chloroform and alcoholic application showed 66.08, 57.10 and 
42.60 % inhibition respectively. [46] 
 
 N. Shekhawat et al., (2010) investigated the crude methanolic extract of Madhuca 
indica at 50, 100 and 200 mg/kg for anti-inflammatory, analgesic and antipyretic 
activities in male Wistar rats. Anti-inflammatory activity was studied by using 
carrageenan-induced oedema right hind paw volume, the analgesic effect was  
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evaluated by acetic acid-induced abdominal pains and the brewer's yeast-induced 
pyrexia model was used for antipyretic investigation. All the doses of the plant 
methanolic extract and the indomethacin significantly inhibited carrageenan-
induced inflammation that was not dose-dependent. The plant extract reduced the 
acetic acid-induced pain licking. The plant extract also reduced the brewer's yeast 
provoked elevated body temperature in rats after 60 min for 50 and 100 mg/kg dose 
range and 30 min for 200 mg/kg dose range. [47] 
 
 Aiyalu Rajasekaran et al., (2010) conducted antipyretic activity on ethyl acetate 
extract of Adenema hyssopifolium in a rat model. It shows significant reduction in 
normal body temperature and brewer’s yeast induced pyrexia in rat on a dose 
dependent manner. The antipyretic activity was compared with standard drug 
paracetamol (150 mg/kg). At the dose of 600 mg/kg it showed significant reduction 
in temperature in pyrexia rats from 2 to 4 h and 300 mg/kg shows significant 
reduction in temperature at 3 and 4 h. Flavonoids were reported for its antipyretic 
action and iridoid glycoside for its analgesic and antiphlogistic activity. [48] 
 
 G.Vinothapooshan et al., (2010) investigated the methanolic, chloroform and 
diethyl ether extracts of Adhatoda vasica plants for its wound healing activity in 
the form of ointment dosage form in excision wound model in albino rats. The 
methanolic extract ointment of Adhatoda vasica showed a significant effect in 
excision wound model as comparable to standard drug (0.2 % w/w Nitrofurazone 
ointment) and other two extracts of ointment, by calculating the parameters, 
percentage closure of excision wound model. [49] 
 
 Sandeep biradar et al., (2010) investigated the anti‐inflammatory, anti‐arthritic, 
analgesic and anticonvulsant activity of essential oils of Cyprus esculentus and 
Cyprus rotundus. The oils were evaluated for carrageenan induced inflammation, 
formaldehyde induced arthritis, formalin induced writhing and MES produced 
convulsion. The results showed dose dependent activity indicated by reduction in 
paw edema in anti-inflammatory and antiarthritic activity, and significant 
reduction in the MES induced convulsion in comparison to control. [50] 
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 Anand Bafna et al., (2010) screened the alkaloidal fraction of roots of 
Cissampelos pareira Linn. (AFCP) for in-vitro antioxidant activity and 
immunomodulatory activity in mice. The HPTLC finger print profile was also 
established for the identification of AFCP which was found to contain 0.176 % of 
berberine. The potential of the extract to serve as antioxidants were assayed by 
DPPH, superoxide radical scavenging activity and by inhibiting lipid peroxidation 
in rat liver homogenate induced by iron/ADP/Ascorbate complex. [51] 
 
 Kumar et al., (2009) evaluated the anti-inflammatory activity of Piper longum 
fruit oil using different doses 0.5 ml/kg and 1 ml/kg orally by using carrageenan-
induced paw edema model. The anti-inflammatory activity was dose dependant 
and found to be statistically significant at the higher concentration to that of 
ibuprofen (100 mg/kg) a standard reference drug. [52] 
 
 S. S. Bhujbal et al., (2009) examined the antioxidant effects of ethanolic extract 
of roots of Clerodendrum serratum at various concentrations in the DPPH radical 
scavenging assay, FRAP assay and the Hydrogen peroxide radical scavenging 
assay. The results revealed that the plant extract has significant antioxidant activity. 
The preliminary phytochemical investigation indicates the presence of flavonoids 
in the plant. So, the antioxidant potential of the plant may be attributed to the 
presence of flavonoids.[53] 
 
 Y Tanko et al., (2008) tested anti-nociceptive and anti-inflammatory effects by 
using the ethanolic extracts of Syzygium aromaticum flower bud. Acetic acid-
induced abdominal contractions in mice and formalin-induced hind paw edema in 
wistar rats were the animal models used. The extract had an LD50 of 565.7 mg/kg 
body weight intraperitoneally in mice. Three doses of the ethanol extract (50, 100, 
and 200 mg/kg) i.p. produced significant effect in both the models. The result 
supports the local use of the plant in painful and inflammatory condition. [54] 
 
 Radhika P. et al., (2008) tested in vitro antibacterial and antifungal activity of 
hexane and methanolic extracts of the roots of Andrographis paniculata. The  
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extracts were found to inhibit the growth of all the bacteria and fungal organisms 
tested. The inhibition produced by the extracts were comparable with the benzyl 
penicillin, standard antibacterial agent and with the fluconazole, standard 
antifungal agent. [55] 
 
 G. Amresh et al., (2007) evaluated 50 % ethanolic extract of the aerial part of 
Cissampelos pareira for anti-inflammatory and analgesic activity in rats and mice 
respectively. Anti-inflammatory activity was investigated by carrageenan induced 
inflammation and arachidonic acid test. Whereas analgesic action of extract was 
evaluated through abdominal writhes and hot plate test. Oral administration of 
extract exhibited significant and dose dependent anti-inflammatory activity in the 
carrageenan test, which was based on interference with prostaglandin synthesis, as 
confirmed by the arachidonic acid test. In the abdominal writhing test induced by 
acetic acid, 200 mg/kg had the highest analgesic activity, whereas in the hot-plate 
test the best dose was 100 mg/kg.[56] 
 
 D. K. Pal et al., (2006) studied in vitro antioxidant activity of the roots and 
rhizomes of Cyperus rotundus. It has been investigated by estimating degree of 
non-enzymatic haemoglobin glycosylation, measured colorimetrically at 520 nm. 
The ethanolic extract of the roots and rhizomes of Cyperus rotundus showed higher 
activity, than other extracts of it. The antioxidant activity of the extracts are close 
and identical in magnitude, and comparable to that of standard antioxidant 
compounds used. The result obtained, indicates that the ethanolic extract has more 
antioxidant activity than the petroleum ether, chloroform, and aqueous extract. [57] 
 
 B. Parimala Devi et al., (2003) evaluated the anti-inflammatory, analgesic and 
antipyretic properties of Clitoria ternatea root against Carrageenan-induced rat 
paw oedema and vascular permeability induced by acetic acid models in rats 
respectively. The extract of root of Clitoria ternatea exhibited a significant 
inhibition of the oedema by 21.6 % and 31.8 %, at 200 and 400 mg/kg respectively. 
Clitoria ternatea also showed significant activity for both analgesic and antipyretic 
model. It was concluded that the methanol extract of Clitoria ternatea possesses 
significant anti-inflammatory, analgesic and antipyretic activities. [58] 
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 Hua-Yew cheng et al., (2003) investigated 6 extracts and 4 pure compounds of 
Terminalia chebula for anti-lipid peroxidation, anti-superoxide radical formation 
and free radical scavenging activities. The superoxide radical scavenging of the 4 
pure compounds was further evaluated using electron spin resonance (ESR) 
spectrometry. The results showed that all tested extracts and pure compounds of 
Terminalia chebula exhibited antioxidant activity at different magnitudes of 
potency. [59] 
 
 S. C. Penna et al., (2003) investigated the effects of crude hydroalcoholic extract 
of ginger rhizomes on rat paw and skin edema. The carrageenan, compound 48/80 
or serotonin induced rat paw edema were inhibited significantly by i.p 
administration of alcoholic ginger extract. Ginger extract was also effective in 
inhibiting 48/80 induced rat skin edema at doses of 0.6 and 108 mg/site. Rat skin 
edema induced by substance P or bradykinin was not affected by treatment with 
ginger extract. The i.p administration of extract (186 mg/kg body wt.) 1 h prior to 
serotonin injections, reduced significantly the serotonin induced rat skin edema. 
Thus the crude extract was able to reduce the rat paw and skin edema induced by 
carrageenan, 48/80 compound and serotonin. [60] 
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3. AIM AND OBJECTIVE 
 
3.1. AIM 
Kabasura kudineer choornam, is a siddha formulation. It is commonly used for the 
treatment of fever with or without respiratory infection.  
The aim of current study is to assess the anti-inflammatory, antipyretic and 
antibacterial effect of aqueous extract of Kabasura kudineer choornam (AEKKC). 
 
3.2. OBJECTIVE 
The objectives of the present study include: 
 Evaluation of in vitro antioxidant activity of AEKKC 
 Acute toxicity study of AEKKC 
 Evaluation of anti-inflammatory, antipyretic and antibacterial activity of 
AEKKC 
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4. PLAN OF WORK 
 
The present study examines the efficacy of Kabasura kudineer choornam, a 
siddha formulation. The effect of the drug was evaluated on various animal models, which 
was designed as follows. 
1. Literature search 
2. Selection of formulation 
3. Aqueous extraction of Kabasura kudineer choornam 
4. Preliminary phytochemical analysis & chromatographic screening 
5. Quantification of total phenol and flavonoid content 
6. In vitro antioxidant activity 
a. DPPH radical scavenging assay 
b. ABTS radical scavenging assay 
7. Acute toxicity studies 
8. Pharmacological Study 
 Screening of anti-inflammatory activity  
a. Carrageenan induced inflammation 
b. Histamine induced inflammation 
 Screening of antipyretic activity  
a. Brewer’s yeast induced pyrexia model 
9. Evaluation of antibacterial activity  
10. Statistical analysis 
11. Documentation of results 
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5. MATERIALS AND METHODS 
5.1. MATERIALS USED FOR THE STUDY 
Table 5: List of instruments 
Sl. No Instruments Manufacturer 
1 Analytical weighing balance Shimadzu 
2 Hot air oven Narang scientific works 
3 HPTLC Camag 
4 Plythesmometer NIVIQURE 
5 UV spectrometer Pharmaspec UV-1700, Shimadzu 
6 Electric water bath Technico 
7 Digital Thermometer Sun pharmaceutical 
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Table 6: List of Chemicals 
Drugs Chemicals Others 
Diclofenac 
Paracetamol 
2, 2’- azinobis 
(3-ethylbenzothiazoline-6-sulfonic 
acid) diammonium salt (ABTS) 
1,1- diphenyl-2-picrylhydrazyl (DPPH) 
Carrageenan 
Brewer’s Yeast 
Histamine 
Quercetin 
Gallic acid 
Rutin 
Folin-Ciocalteau reagent 
Phosphate Buffer 
Potassium Persulfate 
Sodium Carbonate 
10 % Aluminium Chloride 
1 M Potassium acetate 
Distilled water 
Sterile water for injection 
Normal saline 
Syringe 
Needle 
Gloves 
Whatmann No.1 filter 
paper 
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5.2. FORMULATION PROFILE 
5.2.1. NAME 
Kabasura kudineer choornam 
5.2.2. DESCRIPTION 
Decoction is prepared, which consist of water soluble active principles. 
5.2.3. INDICATION 
Fever  
5.2.4. DOSE 
Take 5 g of the powder mix it with 300 ml of water, boil and reduce to 30 ml and give it 
by addition with honey three to four times a day or as directed by the physician.[61] [11] 
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5.2.5. INGREDIENTS OF KABASURA KUDINEER CHOORNAM 
Table 7: Ingredients of Kabasura kudineer choornam 
 
 
 
 
  
Sl. No Ingredients Parts 
1 Zingiber officinale Rhizome 
2 Piper longum Fruit 
3 Syzygium aromaticum Bark, Bud 
4 Tragia involucrate Root 
5 Anacyclus pyrethrum Root 
6 Hygrophilla auriculata Root 
7 Terminalia chebula Fruit 
8 Adathoda vasica Leaf 
9 Coleus ambonicus Leaf 
10 Saussurea lappa Root 
11 Tinospora cardifolia Stem 
12 Clerodendron serratum Root 
13 Andrographis paniculata Whole plant 
14 Cissampelos pareira Root 
15 Cyperus rotandus Rhizome 
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5.2.6. DESCRIPTION OF INDIVIDUAL INGREDIENTS: 
Zingiber officinale: In the fresh ginger rhizome, the gingerols were identified as the major 
active components. The powdered rhizome contains fatty oil, protein, carbohydrates, crude 
fiber, ash, water and volatile oil. In dried ginger powder, shogaol is a predominant. 
Zingiber officinale is non-toxic, highly promising natural antioxidant compound having a 
wide spectrum of biological function such as antimicrobial, anti-inflammatory, 
antioxidant, immunomodulatory, anticarcinogenic activity etc. [62] 
Piper longum: Decoction of immature fruits and roots of piper longum were used in 
chronic bronchitis, cough and cold. Roots and fruits were also used as anti-dote in snake 
biting and scorpion sting. It also shows insecticidal and acaricidal, antifungal, anti-
amoebic, antimicrobial, antiasthmatic, antidiabetic, hypocholesterolaemic, antioxidant, 
analgesic, anti-inflammatory, anti-depressant activity. Piperine is the major constituent. 
Piperine showed marked increase in serum gonadotropins and a decrease in intratesticular 
testosterone concentration, despite normal serum testosterone titres. The fruits also gave 
positive tests for the presence of volatile oil, starch, protein and alkaloids, saponins, 
carbohydrates, and amygdalin. [63] 
Syzygium aromaticum: Used for the treatment of asthma and various allergic disorders. It 
was used ad general antiseptic in medical dental practices. Importantly, due to its 
antioxidant properties clove oil might also be used as an anti-carcinogenic agent. The buds 
oil mainly contains eugenol (49.71%), caryophyllene (18.94%), benzene, 1-ethyl-3- nitro 
(11.12%), benzoic acid, 3-(1-methylethyl) (8.95%), elixene (3.87%), caryophyllene oxide 
(1.53%) and - farnesene (1.11%). [64] 
Tragia involucrate: The roots are bitter, acrid, sweet, cooling possessing diuretic, 
diaphoretic, antiperiodic, depurative and alterant activity. They are useful in pruritic skin 
eruptions, venereal diseases, haemorrhoids, gastropathy, guinea worms, blood impurities, 
dyspepsia, vomiting giddiness, vitiated conditions of pitta, melalgia and brachialgia. It is 
also useful when the extremities are cold during fever and also for pains in the legs and 
arms. The root forms the basis of an external application in leprosy, in old venereal 
complaints and a blood purifier.[65] It shows the presence of alkaloids, carbohydrates, 
protein, tannins, flavonoids, sterols and saponins. And also contains the presence of several  
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colorless phytocompounds such as vinyl hexylether, shellsol, 2, 4 -dimethyl hexane, 2-
methylnanone, and 2, 6-dimethyl heptane. [66] 
Anacyclus pyrethrum: Shows several pharmacological activities and medicinal properties 
like anti-rheumatic, analgesic, antibacterial, antiviral, carminative, anti-catarrhal, 
emmenagogue, febrifuge, nervine, vermifuge, and sialagogue activity. Various 
pharmacological actions such as antidiabetic, immunostimulating effect, inhibitory effects, 
antidepressant activity, anticonvulsant activity, memory-enhancing activity, action on 
COX and LOX has been reported for the plant. Various secondary metabolites such as 
alkaloids, reducing compounds, tannins, flavonoids and coumarins has been identified. 
Chemical analysis of roots shows the presence of three fatty acids, a sterol and ten 
unsaturated amides. The most important compounds discovered in roots are pellitorin, 
anacyclin, phenylethylamine, inulin, polyacetylenic amides I-IV, and sesamin. [67] 
Hygrophila auriculata: Leaves are tonic, hypnotic. Hygrophila auriculata leaves are 
useful in dysentery, thirst, urinary calculi, urinary discharges, inflammations, biliousness, 
anaemia, constipation, anuria, cough and pains in the joints. Seeds are cooling, tonic, 
aphrodisiac, sedative to gravid uterus and constipating. It can be given for gonorrhoea and 
spermatorrhoea. Decoction of the root is used as a diuretic in dropsy. The plant is used in 
cancer and tubercular fistula EtOH (50%) extract of plant is spasmolytic and hypotensive. 
Aerial parts contains alkaloids, phytosterol, lupeol, stigmasterol etc. The seeds contain 
asterol I, II, III and IV and asteracanthine & asteracanthicine. Apigenin glucuronide is 
isolated from the flowers. And Roots contain an essential oil. Palmitic, stearic, oleic and 
linoleic 80.1%) acids have been detected in seed oil. [68] 
Terminalia chebula: Terminalia chebula contains 32% of tannin. Terminalia chebula are 
of pyrogallol type. They contain 14 components of hydrolysable tannins (gallic acid, 
chebulic acid, punicalagin, chebulanin, corilagin, neochebulinic, ellagic acid, chebulegic 
acid, chebulinic acid , 1, 2, 3, 4, 6 -penta -O galloyl-ß-D-glucose, 1, 6,-di-O-galloyl-D-
glucose, casuarinin, 3, 4, 6-tri-O-galloyl-D-glucose and terchebulin). Flavonol glycosides, 
triterpenoids, chebulin, as well as phenolic compounds were also isolated. In addition, 
ethyl gallate and luteolin were also isolated from the fruit of Terminalia chebula. In Unani 
system, it is used as a blood purifier. The pulp of the fruit is given in piles, chronic diarrhea,  
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dysentery, costiveness, flatulence, asthma, urinary disorder, vomiting, hiccup, intestinal 
worms, ascites and enlarged spleen and liver. Terminalia chebula showed a melanin 
inhibitory effect higher than 90%. [69] [70] [71] 
Adathoda vasica: The vast variety of pharmacological uses of Adhatoda is believed to be 
the result of its rich concentration of alkaloids. The prominent alkaloid found in Adhatoda 
leaves is vasicine, a quinazoline alkaloid. The leaves and roots of Adhatoda, in addition to 
vasicine, contains the alkaloids l-vasicinone, deoxyvasicine, maiontone, vasicinolone and 
vasicinol. These are responsible for adhatoda’s bronchodilatory effect. Cholagogue 
activity, anti-tubercular activity, abortifacient and uterotonic activity, anti-allergy activity 
are some other pharmacological activity. [72] 
Coleus aromaticus: It is known to possess antimicrobial, antiepileptic, leishmanial, and 
antioxidant activities. The leaves are also used for treatment of cough, throat infection and 
nasal congestion. [73] 
Saussurea lappa: Costunolide is one of the major bioactive constituent of Saussurea lappa 
root. Traditionally it has been used for the treatment of large number of diseases such as 
asthma, cough, throat infections, tuberculosis, leprosy, malaria, convulsions, fever, 
helminthic infestations and as antispasmodic. And also reported pharmacological actions 
such as antiulcerogenic, cytotoxic, anti-inflammatory, anti-epileptic, antibacterial, 
hepatoprotective, immunomodulatory, anticonvulsant, angiogenesis, antidiarrheal, 
antihyperlipidemic activity etc. [74] 
Tinospora cordifolia: The therapeutic properties of medicinal plants are attributed owing 
to the presence of active substances such as alkaloids, flavonoids, glycosides, vitamins, 
tannins, and coumarins. [75] From the stem of Tinospora cordifolia alkaloid berberin, 
tinosporin and palmitin were isolated. From the whole plant of Tinospora cordifolia, the 
diterpenoidal lactone tinosporide and tinosporon were obtained. In ayurvedic system of 
medicine it is widely used for general tonic, antiperiodic, anti-spasmodic, anti-
inflammatory, anti- arthritic, anti-allergic, antidiabetic properties and also to improve the 
immune system and the body resistance against infections. The stem is bitter, stomachic, 
diuretic, stimulates bile secretion, causes constipation, allays thirst, enriches the blood and 
cures jaundice. The extract of its stem is useful in skin problems. [76] 
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Clerodendrum serratum: Root reported the presence of flavonoids, glycosides, saponins, 
sterols and absence of alkaloids and terpenoids. The root bark contain D-mannitol. Its roots 
are bitter, acrid, thermogenic, anti-inflammatory, anthelmintic, depurative, expectorant, 
sudorific, antispasmodic, stimulant and febrifuge. The root also increases appetite, lessens 
expectoration. [77]Aqueous extracts of leaves of Clerodendrum serratum possess 
bronchodilator property. Previous studies suggests that apigenin-7-glucoside has 
demonstrated anti-inflammatory, antimicrobial, hepatoprotective and anti-diarrheal 
properties. The compound also showed significant protection against Alzheimer’s disease 
in mice. [78] 
Andrographis paniculata:  Andrographolide is the major constituent. Some other known 
constituents are Neoandrographolide, Paniculide-A, Paniculide-B, Paniculide-C etc. [79] In 
China, India, Thailand and Malaysia, this has been widely used for treating sore throat, 
common cold, flu and upper respiratory tract infections. In Ayurvedic system of medicine 
it is used as carminative, liver stimulant, immune system stimulant, anthelmintic, blood 
purifier, anti-inflammatory, antipyretic, anti-malarial and in prevention of infections. In 
Siddha system of medicine it is used for treating cancer. Andrographis paniculata either 
alone or with neem or papaya juice/extract can use for the management of malarial fever, 
dengue fever, chikungunya and common flu. [80] 
Cissampelos pareira: The roots are bitter astringent, carminative, digestive, anti-
inflammatory, and pungent. And also shows diuretic, febrifuge, expectorant, galactagogue 
activity. It is useful in dyspepsia, indigestion, flatulence, abdominal pains, diarrhoea, 
dysentery, blood disorders, cardiac disorders, edema, leprosy, sensation, asthma, 
bronchitis, cystitis, dysuria and lactation disorders also. In addition it is useful in non-
healing ulcers, skin disorders, scabies, migraine, leucorrhoea and gonorrhea. It mainly 
consists alkaloids, such as hayatine, hayatinine, hayatidine and other 
bisbenzylisoquinoline alkaloids. [81] 
Cyperus rotundus: Cyperus rotandus are useful in treatment of fever, malaria, cough, 
bronchitis, renal and vesical calculi, skin diseases, wounds, amenorrhoea, dysmenorrhoea, 
loss of memory, insect bites, food poisoning, infertility, cervical cancer and menstrual 
disorders. And also useful for dietary management of psychotic diseases and metabolic  
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disorders. Cyperus rotandus rhizomes revealed the presence of alkaloids, flavonoids,  
tannins, starch, glycosides, furochromones, monoterpenes, sesquiterpenes, sitosterol, fatty 
oil containing a neutral waxy substance, glycerol, linolenic, myristic and stearic acids. The 
major compounds isolated from essential oil and the extracts of Cyperus rotundus rhizome 
are α-cyperone, α-rotunol, β-cyperone etc. [82] 
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5.3. METHODOLOGY 
5.3.1. COLLECTION OF THE FORMULATION 
Kabasura kudineer choornam was procured from Siddha Practioner Dr. K. Anbarasu, 
Trichy. 
5.3.2. EXTRACTION OF THE FORMULATION [83] 
Preparation of extracts: An aqueous extract of Kabasura kudineer choornam (100 gm) 
was prepared by heating the mixture at 50-60º C till water reduces to 1/8th of its volume. 
This procedure involves simple decoction process to obtain the soluble materials being 
extracted from the crude raw plants, which was then cooled and filtered. The filtrate that 
obtained by decoction process was then concentrated. The concentrated aqueous extract 
of Kabasura kudineer choornam (AEKKC) was stored at 2-5 °C until completion of study. 
5.3.3. QUALITATIVE PHYTOCHEMICAL ANALYSIS [84] [85] [86] [87] 
Preparation of test sample 
500 mg of the extract was dissolved in 5 ml of distilled water and then filtered. The filtrate 
was tested to detect the presence of various phytochemical constituents in the sample. 
5.3.3.1. TEST FOR CARBOHYDRATES 
 Molisch’s test 
A few drops of Molisch’s reagent were added to 2-3 ml of filtrate, and concentrated 
sulphuric acid was added along the sides of the test tube. Violet colour ring formed at the 
junction of two liquids indicates the presence of carbohydrates. 
 Fehling’s test 
Equal volume of Fehling’s- A [copper sulphate in distilled water] and Fehling’s- B 
[potassium tartarate and sodium hydroxide in distilled water] reagents were mixed in a test 
tube and boiled for one minute. 1ml of sample was added to the above mixture and heated 
for few minutes. Brick red precipitate formed confirms the presence of sugars. 
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 Benedict’s test 
The test sample was mixed with equal volume of Benedict's reagent (alkaline solution 
containing cupric citrate complex) in a test tube and heated for few minutes. Formation of 
brick red precipitate confirms the presence of sugars. 
5.3.3.2. TEST FOR ALKALOIDS 
Small amount of extract was mixed with few ml of dilute hydrochloric acid and filtered. 
The following tests were performed with the filtrate: 
 Dragendorff’s test 
Few drops of the Dragendorff’s reagent (Sodium iodide, basic bismuth carbonate, glacial 
acetic acid and ethyl acetate) were added to 2-3 ml of filtrate. Development of orange 
brown precipitate indicates the presence of alkaloids. 
 Mayer’s test 
The filtrate was treated with few drops of Mayer's reagent (mercuric chloride and 
potassium iodide). Formation of yellowish buff coloured precipitate indicates the presence 
of alkaloids. 
 Wagner’s test 
A few drops of filtrate were treated with Wagner's reagent (solution of iodine in potassium 
iodide) and a reddish brown precipitate obtains to indicate the presence of alkaloids.  
 Hager’s test 
A few drops of Hager’s reagent were added to 2-3 ml of filtrate. Development of yellow 
precipitate indicates the presence of alkaloids. 
5.3.3.3. TEST FOR TRITERPENOID 
 Libermann-Burchard test 
A small quantity of extract was treated with few drops of acetic anhydride, followed by a 
few drops of concentrated sulphuric acid. A brown ring was formed at the junction of two 
layers and the upper layer turns green colour, infers the presence of phytosterols and  
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formation of deep red colour indicates the presence of triterpenoids. 
 Salkowski test 
A small quantity of the extract was treated with chloroform and few drops of concentrated 
sulphuric acid and allowed to stand for few minutes. Yellow colour at the lower layer 
indicates the presence of triterpenoids. 
5.3.3.4. TEST FOR GLYCOSIDES 
 Legal’s test 
2 ml of extract was dissolved in pyridine. Sodium nitroprusside solution was added to it 
and made alkaline. Pink red colour formed indicates the presence of glycosides. 
 Keller-Killiani test 
2 ml of extract was dissolved in acetic acid containing trace of ferric chloride and 
transferred to the surface of concentrated sulphuric acid. At the junction of two liquids, a 
reddish brown color formed, which gradually became blue colour due to the presence of 
glycosides. 
 Baljet test 
2 ml of extract was added to sodium picrate solution. Yellow to orange colour was formed 
indicating the presence of glycosides. 
5.3.3.5. TEST FOR STEROIDS AND STEROLS 
 Liebermann- Burchard reaction 
The test sample was dissolved in 2 ml of chloroform in a dry test tube. Few drops of acetic 
anhydride were added followed by 2 drops of concentrated sulphuric acid. The solution 
becomes red, then blue and finally bluish green in colour. 
 Salkowski reaction 
Extract was dissolved in chloroform and concentrated sulphuric acid was added to it. 
Bluish red, cherry red and purple colour was noted in chloroform layer, whereas acid layer 
was marked with green fluorescence. 
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5.3.3.6. TEST FOR TANNINS 
 Lead acetate test 
1 ml of alcoholic solution of extract was diluted with 5 ml of distilled water and to this 
few drops of 1% aqueous solution of lead acetate was added. A yellow colour precipitate 
was formed which indicates the presence of phenols. 
5.3.3.7. TEST FOR SAPONINS 
 Foam Test 
About 1 ml of test sample was diluted separately with distilled water to 20 ml and shaken 
in a graduated cylinder for 3 minutes. Foam of 1cm after 10minutes indicates the presence 
of saponins. 
 Froth test: 
A drop of sodium bicarbonate was added to 5 ml of the test sample. The mixture was 
shaken vigorously and kept for 3minutes. A honey comb like froth was formed which 
shows the presence of saponins. 
5.3.3.8. TEST FOR PHENOLS 
 Ferric chloride test 
1 ml of the alcoholic solution of the extract mixed with 2 ml of distilled water followed by 
few drops of 10% ferric chloride. Formation of blue or green colour indicates the presence 
of phenols. 
 Lead acetate test 
1 ml of alcoholic solution of extract was diluted with 5 ml of distilled water and, few drops 
of 1% aqueous solution of lead acetate was added. A yellow colour precipitate was formed 
which indicates the presence of phenols. 
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5.3.3.9. TEST FOR FLAVONOIDS 
 Alkaline reagent test 
A few drops of sodium hydroxide solution was added to the extract. Intense yellow colour 
turned to colourless on addition of few drops of dilute hydrochloric acid, indicates the 
presence of flavonoids. 
 Shinodas test [Magnesium hydrochloride reduction test] 
A small piece of magnesium ribbon and few drops of concentrated hydrochloric acid were 
added to the alcoholic solution of extract and heated. Appearance of crimson red or 
occasionally green to blue colour infers the presence of flavonoid. 
5.3.3.10. TEST FOR PROTEINS AND AMINO ACIDS 
 Biuret test 
1 ml of test sample was mixed with 1 ml of 40 % sodium hydroxide and 2 drops of 1% 
copper sulphate. Formation of violet colour indicates the presence of proteins. 
 Ninhydrin test 
1 ml of test sample heated with 2 drops of freshly prepared 0.2% Ninhydrin reagent. 
Development of blue colour indicates the presence of proteins, peptides or amino acids 
5.3.4. HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY [88] 
HPTLC has emerged as an important tool for the qualitative and semi quantitative and 
quantitative phytochemical analysis of herbal drugs. HPTLC has excellent resolution and 
therefore it permits simultaneous identification of several samples in a single run, using a 
small quantity of mobile phase. It is a high output, time saving and a rapid low cost 
analytical method. 
Preparation of standard solution 
Stock solutions of standard compounds were prepared by dissolving accurately weighed 
1mg of Gallic acid, Rutin, Quercetin, Ferrulic acid, Andrographolide, and Ellagic acid in 
1 ml of methanol (HPTLC grade). And 5 μl of each standard were spotted on the HPTLC 
plate.  
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Preparation of Sample  
Accurately weighed 1 g of Kabasura kudineer choornam and dissolved separately in 10 ml 
methanol and water. Also weighed 1 g of AEKKC and dissolve in 10 ml water. Each 
sample was then filtered by using Whatmann No.1 filter paper. 10 μl of 3 samples were 
spotted on the HPTLC plate. 
Experimental condition 
Stationary phase  : Aluminium plates precoated with Silica Gel 60F254 
  (10×10×0.2) mm thickness 
Mobile phase : Toluene: Ethyl acetate: Formic acid: Methanol          
(3:6:1.6:0.4) 
Sample for HPTLC : Kabasura Kudineer choornam, AEKKC, Standard 
Quercetin, Rutin, Gallic acid, Ferrulic acid, 
Andrographolide, Ellagic acid solutions. 
Materials and methods 
Sample application  : Camag Linomat 5 
Chamber type   : Twin trough Chamber 10× 10 cm 
Chamber saturation  : 5 min 
Development time  : 30 min 
Development distance : 7 cm 
Detection   : Camag Scanner 3 
Data system   : win CATS Planar Chromatography Manager. 
Instrumental Parameters 
Number of track  : 9 
Band length   : 6.0 mm 
Application position  : 10 mm 
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Solvent front position  : 80.0 mm 
Solvent volume  : 10 ml 
Position of first track  : 10 mm 
Distance between tracks : 10 mm 
Scan start position Y  : 5.0 mm 
Scan end position  : 75.0 mm 
Slit dimension   : 6.00 × 0.45mm, Micro 
Optimized optical system : light 
Scanning speed  : 20 mm/sec 
Data resolution  : 100 μM/ step 
Measurement table 
Wavelength   : 254 nm 
Lamp    : D2 and W 
Measurement   : remission 
Measurement mode  : absorption 
Optical filter   : second order 
Detector mode  : automatic 
Procedure 
The standards; gallic acid, rutin, quercetin, ferrulic acid, andrographloide, ellagic acid 
(5μl) and samples; Kabasura Kudineer choornam in methanol, AEKKC in water and 
Kabasura Kudineer choornam in methanol (10 µl) were spotted in form of bands with a 
Camag microlite syringe on pre-coated Silica Gel glass plate 60F254 (10×10 cm with 
0.2mm thickness) using a Camag Linomat 5 applicator. The plates were pre-washed with 
methanol and activated at 600 C or 10 min prior to chromatography. The sample loaded 
plate was kept in TLC twin trough developing chamber after chamber saturation with  
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respective mobile phase. The optimized chamber saturation time for mobile phase was 5 
min at room temperature. Linear ascending development was carried out and the plate was 
developed in the respective mobile phase up to 7 cm. The developed plate was then dried 
by hot air to evaporate solvents from plate and also for the development of bands. The 
dried plate was observed under UV light at 254 nm and 366 nm and photo documentation 
was done. Densitometric scanning was performed on Camag TLC scanner 3 in the 
absorbance mode at 280 nm. The percentage of active constituents present in the extract 
was compared with that of standard. 
5.3.5. QUANTIFICATION OF TOTAL PHENOLICS AND FLAVONOIDS [89] 
5.3.5.1. ESTIMATION OF TOTAL PHENOLICS 
Reagents 
Folin-Ciocalteu’s reagent 
Gallic acid (1mg/ml) 
20% sodium carbonate 
Preparation of standard 
Standard solution was prepared by adding 10 mg of accurately weighed Gallic acid in 10 
ml of distilled water. 
Preparation of sample 
10 mg of the accurately weighed extract was dissolved in 10 ml water and used for the 
estimation. 
Procedure 
The total phenolic content of the extract was determined by Folin-Ciocalteau assay 
method. To an aliquot 100 μl of extract (or standard solution of Gallic acid (10, 20, 40, 60, 
80, 100 μg/ml) added 50 μl of Folin-Ciocalteau reagent followed by 860 μl of distilled 
water and the mixture is incubated for 5 min at room temperature. 100 μl of 20% sodium 
carbonate and 890 μl of distilled water were added to make the final solution to 2 ml. It 
was incubated for 30 min in dark to complete the reaction. The absorbance of the mixture  
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was measured at 725 nm against blank. Distilled water was used as reagent blank. The 
tests were performed in triplicate to get mean the values. The total phenolic content was 
found out from the calibration curve of Gallic acid. And it was expressed as milligrams of 
Gallic acid equivalents (GAE) per gram of extract. 
5.3.5.2. ESTIMATION OF TOTAL FLAVONOIDS 
Reagents 
Methanol 
10% aluminium chloride 
1M Potassium acetate 
Preparation of standard 
Standard solution was prepared by adding 10 mg of accurately weighed quercetin in 10 ml 
of ethanol. 
Preparation of sample 
10 mg of the accurately weighed extract was dissolved in 10 ml ethanol and used for the 
estimation. 
Procedure 
The total flavonoid content of the AEKKC was determined by using Aluminium chloride 
colorimetric method. To an aliquot of 100 μl of extract or standard solutions of Quercetin 
(10, 20, 40, 60, 80, 100 μg/ml) ethanol was added separately to make up the solution upto 
2 ml. The resulting mixture was treated with 0.1 ml of 10% aluminium chloride, 0.1 ml of 
1 M potassium acetate and 2.8 ml of distilled water. Shaken well and incubated at room 
temperature for 30 minutes. The absorbance was measured at 415 nm against blank, where 
a solution of 2 ml ethanol, 0.1 ml potassium acetate, 2.8 ml distilled water and 0.1 ml of 
aluminium chloride serve as blank solution. The total flavonoid content was determined 
from the standard Quercetin calibration curve and it was expressed as milligrams of 
Quercetin equivalents (QE) per gram of extract. 
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5.3.6. IN VITRO-ANTIOXIDANT STUDIES 
5.3.6.1. DPPH FREE RADICAL SCAVENGING ASSAY [90] 
Principle 
The molecule of 1, 1-diphenyl-2-picrylhydrazyl (α, α-diphenyl-β-picrylhydrazyl; DPPH) 
is characterized as a stable free radical by virtue of the delocalization of the spare electron 
over the molecule as a whole, so that the molecules do not dimerise, as would be the case 
with most other free radicals. The delocalization also gives rise to the deep violet colour, 
characterized by an absorption band in ethanol/methanol solution centred at about 520 nm. 
When a solution of DPPH is mixed with that of a substance that can donate a hydrogen 
atom, then this gives rise to the reduced form with the loss of this violet colour (although 
there would be expected to be a residual pale yellow colour from the picryl group still 
present). Representing the DPPH radical by Z• and the donor molecule by AH, the primary 
reaction is Z• + AH = ZH + A•. 
Procedure 
The antioxidant activity of the extract was measured in terms of hydrogen donating or 
radical scavenging ability using the stable DPPH radical (Blois method).0.3 mM solution 
of DPPH in methanol was prepared and 1 ml of this solution was added to 1 ml of various 
concentrations of sample (10, 20, 40, 60, 80 and100 μg/ml) and the reference compound 
quercetin (5, 10, 15, 20, 25 and 30 μg/ml) shaken vigorously and left to stand in the dark 
at room temperature for 30 min and then absorbance was measured at 517 nm against a 
blank. Reference compound used here was ascorbic acid. A control reaction was carried 
out without the test sample. All the tests were performed in triplicate in order to get the 
mean values. The percentage of inhibition was calculated by comparing the absorbance 
values of the control and test samples. Antiradical activity was expressed as percentage 
inhibition (I %) and calculated using the following equation: 
Percentage inhibition (I %) = (Abs control- Abs sample /Abs control) X 100 
Different sample concentrations were used in order to obtain calibration curves and to 
calculate the IC50 values. (IC50 - concentration required to obtain a 50% radical scavenging 
activity). 
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5.3.6.2. ABTS FREE RADICAL SCAVENGING ASSAY [91] 
In ABTS decolourization assay, the peroxidase substrate 2, 2’- azinobis (3-
ethylbenzothiazoline- 6-sulfonic acid) (ABTS), forms a relatively stable radical (ABTS+) 
upon one electron oxidation. This assay is based on the scavenging of light by ABTS 
radicals. An antioxidant with an ability to donate a hydrogen atom will quench the stable 
free radical and inhibits the absorption of the radical cation which has characteristic long-
wavelength absorption spectrum showing maxima at 660, 734, and 820 nm. The relatively 
stable ABTS radical has a green colour and is quantified spectrometrically at 734 nm. 
Procedure 
ABTS radical scavenging activity of the extract was measured by Rice-Evans method. 
ABTS was dissolved in water to a 7 mM concentration. ABTS radical cation (ABTS+) was 
produced by reacting ABTS stock solution with 2.45 mM potassium persulfate and 
allowing the mixture to stand in the dark at room temperature for 12- 16 h before use. The 
radical was stable in this form for more than 2 days when stored in the dark at room 
temperature. For the study, ABTS solution was diluted with phosphate buffer saline pH 
7.4 (PBS) to an absorbance of 0.70 (± 0.02) at 734 nm and equilibrated at 30 0C. After 
addition of 1 ml of diluted ABTS solution to various concentrations of sample (1, 2, 4, 6, 
8, and 10 μg/ml) or reference compound (0.25, 0.5, 0.75, 1, 1.25 and 1.5 μg/ml) the 
reaction mixture was incubated for 6 min and then absorbance was measured at 734 nm 
against a blank. A control reaction was carried out without the sample. All the tests were 
performed in triplicate in order to get the mean values. The percentage inhibition of ABTS+ 
by the sample was calculated according to the formula: 
Percentage inhibition (I %) = (Abs control- Abs sample /Abs control) X 100 
Different sample concentrations were used in order to obtain calibration curves and to 
calculate the IC50 values. (IC50 - concentration required to obtain a 50% radical scavenging 
activity). 
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5.3.7. PHARMACOLOGICAL STUDY 
ANIMALS 
Male Wistar rats of 6-8 weeks old and 160-180 g body weight were offered by KMCH 
College of pharmacy, Coimbatore. All rats were housed and maintained under standard 
conditions of temperature (25 0C ± 5 0C), relative humidity (55 ± 10%), and 12/12 h 
light/dark cycle. Animals were fed with commercial pellet diet and water ad libitum freely 
throughout the study. Protocols for the study were approved by the Institutional Animal 
Ethical Committee (IAEC) for Animal Care and were in accordance with Committee for 
the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) guidelines, 
Government of India. 
5.3.7.1. ACUTE TOXICITY TEST 
Acute oral toxicity study was performed as per OECD-423 guidelines. The mices were 
fasted overnight with free excess of water and were grouped into four group consisting of 
3 animals each, to which the extract was administered orally at the dose level of 5 mg/kg, 
50 mg/kg, 300 mg/kg and 2000 mg/kg body weight. They were observed for mortality; 
toxic symptoms such as behavioral changes, locomotor activity, convulsions; direct 
observation parameters such as tremor, convulsion, salivation, diarrhoea, sleep, coma, 
changes in skin and fur, eyes and mucous membrane, respiratory, circulatory, autonomic 
and CNS, somatomotor activity etc. periodically for 30 min during first 24 h. And specific 
attention given during first 4 hours daily for a total period of 14 days 
5.3.7.2. SCREENING OF ANTI-INFLAMMATORY ACTIVITY  
Experimental methods 
Anti-inflammatory activity was assessed by carrageenan and histamine induced rat paw 
edema methods 
 CARRAGEENAN INDUCED PAW EDEMA IN RATS 
Experimental design 
Wistar albino rats weighed around 150-250 g were used for the study. Rats were divided 
into four groups of 6 animals each. 
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Table 8: Experimental design for carrageenan induced paw edema 
GROUPS TREATMENT 
Group I Carrageenan 1% w/v (0.1 ml, subplantar ) 
Group II Diclofenac (20 mg/kg), p.o 
Group III AEKKC ( 200mg/kg), p.o 
Group IV AEKKC (400mg/kg), p.o 
Procedure [39] [92] [93] 
The rats were divided into four groups of 6 animals each. The group II was treated with 
diclofenac (20 mg/kg) p.o and group III and IV were treated with 200 and 400 mg/kg of 
AEKKC respectively. Treatments were given 30 min before the administration of 
carrageenan. The rats were then challenged with subcutaneous injection of 0.1 ml of 1% 
w/v solution of carrageenan into the sub plantar region of left paw. The paw was marked 
with ink at the level of lateral malleolus. The paw volume was measured before (0 h) and 
after carrageenan injection at 1, 2, 3, 4, 5 h by volume displacement method using 
plythesmometer. The difference of average values between treated animals and control 
group is calculated for each time interval and evaluated statistically. The percentage 
inhibition (PI) of paw edema was calculated by using the following formula; 
Percentage of edema inhibition = (Vc - Vt/Vc) × 100 
Vc = Mean edema volume in control 
Vt = Mean edema volume in group treated with standard or extract 
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 HISTAMINE INDUCED RAT PAW EDEMA [39] [94] 
Experimental design 
Wistar albino rats were divided into four groups of 6 animals each. 
Table 9: Experimental design for histamine induced paw edema 
GROUPS TREATMENT 
Group I 0.1 ml of freshly prepared histamine 
(0.1%) 
Group II Diclofenac (20 mg/kg), p.o 
Group III AEKKC (200 mg/kg), p.o 
Group IV AEKKC ( 400 mg/kg), p.o 
 
Procedure 
One hour after the drug treatment, inflammation was induced by injection of 0.1 ml of 
freshly prepared histamine (1%) in normal saline underneath the plantar tissue of the right 
hind paw of rats. Paw volume, measured using a plythesmometer before histamine 
administration and at 1, 2, 3 h after histamine injection. The percentage inhibition (PI) of 
paw edema was calculated by using the following formula; 
Percentage of edema inhibition = (Vc - Vt/Vc) × 100 
Vc = Mean edema volume in control 
Vt = Mean edema volume in group treated with standard or extract 
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5.3.7.3. SCREENING OF ANTIPYRETIC ACTIVITY 
 BREWER’S YEAST INDUCED PYREXIA MODEL [28] 
Experimental design 
Wistar albino rats were divided into four groups of 6 animals each. 
Table 10: Experimental design for brewer’s yeast induced pyrexia model 
GROUP TREATMENT 
Group I 10 ml/kg of 15% w/v Brewer’s yeast 
suspension 
Group II Paracetamol 150mg/kg, p.o 
Group III AEKKC (200mg/kg), p.o 
Group IV AEKKC ( 400mg/kg), p.o 
 
By insertion of a Digital thermometer to a depth of 2 cm into the rectum, the initial rectal 
temperatures were recorded. The fever was induced in animal by injection of 10 ml/kg of 
15 % w/v Brewer’s yeast suspension in normal saline subcutaneously in the back below 
the nape of the neck. The site of injection is massaged in order to spread the suspension 
beneath the skin. The room temperature kept at 22-24 0C. Immediately after Brewer’s yeast 
administration, food is withdrawn. 18 h post challenge, the rise in rectal temperature was 
recorded. The measurement is repeated after 30 min. Only those rats which showed an 
increase in temperature of at least 0.6 0C (10 F) were used for further experiment. Fever 
induced rats were divided into four groups of six animals each. The animals were then 
received the test and standard drug by oral administration. After the drug administration 
the rectal temperature of all the rates in each group was recorded periodically at an interval 
of 1, 2, 3, 4, and 5 h of the drug administration. The percentage decrease in pyrexia was 
calculated by the following formula: 
Percent reduction = (B – Cn ) / (B – A) × 100 
B represents temperature after pyrexia induction;  
Cn temperature after 1, 2, 3, 4 and 5 h 
A is normal body temperature. 
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5.3.8. ANTI-BACTERIAL ACTIVITY [95] [96] 
5.3.8.1. ZONE OF INHIBITION  
Preparation of inoculums  
The inoculums for the experiment were prepared in fresh Nutrient broth from the preserved 
slant culture. The turbidity of the culture can be adjusted by the addition of broth or sterile 
saline (if it is excessive) or by further incubation to get the required turbidity, and the 
newly prepared inoculums were standardized by adjusting the turbidity of the culture to 
that of McFarland standards.  
Preparation of sterile swabs  
Cotton wool swab on wooden applicator or plastics were prepared and sterilized by 
autoclaving or by dry heat (only for the wooden swabs). It was sterilized by packing the 
swabs in culture tubes.  
Sterilization of forceps  
Forceps was sterilized by dipping in alcohol and burning off the alcohol.  
Procedure  
The standardized inoculums were inoculated in the sterilized plates prepared earlier 
(aseptically) by dipping a sterile loop into the inoculums. The excess inoculums was 
removed by passing and rotating the swab firmly against the side of the culture tube above 
the level of the liquid and streaking the swab all over the surface of the medium 3 times 
rotating the plate through an angle of 60º after each application. Finally pass the swab 
round the edge of the agar surface. Leave the inoculums to dry at room temperature with 
the lid closed. The sterile discs were soaked overnight in sample solution. Each Petri dish 
was divided into 2 parts. First compartment of the plate were loaded with AEKKC disc 
(200 μg) and the second compartment with Std ciprofloxacin disc (10 μg) with the help of 
sterile forceps. After that the petri dishes are placed in the refrigerator at 4º C or at room 
temperature for 1 hour for diffusion. Incubate at 37 º C for 24 hours. Observe the zone of 
inhibition produced. Measure it using a scale and record the average of two diameters of 
each zone of inhibition. 
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Table 11: Bacterial strain used for the study with NCIM 
Sl. No Organism Strain NCIM 
1 Gram +ve  Bacteria Staphylococcus aureus 2079 
2 Bacillus subtilis 2063 
1 Gram – ve  Bacteria Pseudomonas aeuroginosa 2200 
2 Escherichia coli 2065 
 
5.3.8.2. MINIMUM INHIBITORY CONCENTRATION 
The minimum inhibitory concentration (MIC) is the lowest concentration of a chemical 
that prevents the visible growth of the organism i.e., the lowest concentration at which it 
has bacteriostatic activity. 
Preparation of test drug: 
The AEKKC was prepared in DMSO at a concentration 2000 μg/ml 
Preparation of inoculum: 
Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeuroginosa, Escherichia coli 
were the four strains of organisms selected for the study. Overnight culture are grown at 
37 0C Kirby- Bauer procedure and diluted to Muller Hinton Broth. This overnight culture 
was diluted to 10-2. 
Inoculation: 
The sterile tubes were labelled 1-8 and 8th tube was taken as control. 1 ml of Muller Hinton 
Broth was transferred to all tubes. 1 ml of drug solution was added to 1st tube and mixed 
well. From the 1st tube 1 ml of solution was transferred to the 2nd tube and was repeated 
up to 7th tube. From the final 2 ml volume of 7th tube 1 ml of solution was pipette out. 0.01 
ml of culture was added to all the test tubes and all the tubes were incubated at 37 0C for 
18-24 hrs. After incubation the turbidity was observed visually. The highest dilution 
without growth is the minimal inhibitory concentration. 
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5.3.9. STATISTICAL ANALYSIS  
Data were analyzed by one way ANOVA followed by Dunnetts’s multiple comparison test 
using Graphpad 5.0 software. The values were expressed as Mean ± SEM. P<0.05 was 
considered significant 
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6. RESULTS 
 
6.1. PRELIMINARY PHYTOCHEMICAL ANALYSIS 
 
Table 12: Phytochemical analysis 
 
Sl. No Phytochemical constituents AEKKC 
1 Carbohydrates Positive 
2 Glycosides Positive 
3 Alkaloids Positive 
4 Phenolics Positive 
5 Flavonoids Positive 
6 Tannins Positive 
7 Triterpenoids Positive 
8 Saponins Positive 
9 Steroids Positive 
10 Proteins and amino acids Negative 
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6.2. QUANTIFICATION OF TOTAL PHENOL AND FLAVANOIDS 
6.2.1 ESTIMATION OF TOTAL PHENOL OF AEKKC 
Table 13: Estimation of total phenolic content of AEKKC  
Sample Concentration (μg/ml) Absorbance at 725 nm 
 
 
Standard 
(Gallic acid) 
 
10 0.087 
20 0.118 
40 0.205 
60 0.336 
80 0.401 
100 0.495 
Sample(AEKKC) 100 0.356 
 
Figure 4: Standard graph for Gallic acid for the estimation of total phenolic content 
 
 
The total phenolic content in AEKKC was found to be 68.27 mg/g of extract calculated as 
Gallic acid equivalent. 
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6.2.2. ESTIMATION OF TOTAL FLAVONOID CONTENT OF AEKKC  
Table 14: Estimation of total flavonoid content of AEKKC 
Sample Concentration (μg/ml) Absorbance at 415 nm 
 
 
Standard 
(Quercetin) 
10 0.1150 
20 0.2150 
40 0.4160 
60 0.6579 
80 0.9571 
100 1.1135 
Sample(AEKKC) 100 0.3643 
 
Figure 5: Standard graph of Quercetin for the estimation of total flavonoid content 
 
 
The total flavonoid content in AEKKC was found to be 32.99 mg/g of extract calculated 
as quercetin equivalent 
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6.3. ESTIMATION OF PHYTOCONSTITUENTS BY HIGH PERFOMANCE 
THIN LAYER CHROMATOGRAPHY (HPTLC) 
HPTLC study was carried out for the quantification of phytoconstituents in extract. After 
development the plate was scanned in densitometer under 254 nm and the chromatogram 
obtained is depicted in figure 7. 
Figure 6: Detection of bands 
 
 
Table 15: Lists of spots applied on HPTLC plate 
Track number Sample Volume Sample 
1 10 KKC in methanol  
2 10 AEKKC in water 
3 10 KKC in water  
4 5 Quercetin 
5 5 Rutin 
6 5 Gallic acid 
7 5 Ferrulic acid 
8 5 Andrographloide 
9 5 Ellagic acid 
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3D DISPLAY OF CHROMATOGRAM OF STANDARDS & SAMPLES 
 
Figure 7: 3D display of chromatogram of Samples and Standards 
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Figure 8: Chromatogram of Standards and Samples 
 
             Track 1: KKC in methanol 
 
 
                                                                                     Track 2: AEKKC in water 
 
  
                Track 3: KKC in water 
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                    Track 4: Quercetin  
 
 
  
 
 
 
 
 
 
    Track 5: Rutin 
 
 
                      Track 6: Gallic acid 
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 Track 7: Ferrulic acid 
 
6.3.1 QUANTIFICATION OF QUERCETIN AND GALLIC ACID IN EACH 
SAMPLES 
Table 16: Amount of Quercetin & Gallic acid present in each samples 
Sl. No Track Sample 
Volume in 
µl 
% of Quercetin 
in 1000 µg of  
extract 
% of Gallic 
acid 
in 1000 µg of  
extract 
1 Track 1 
KKC in 
methanol 
10 µl 0.03 % 0.14 % 
2 Track 2 AEKKC 10 µl 0.06 % 0.37 % 
3 Track 3 
KKC in 
water 
10 µl 0.02 % 0.177 % 
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6.4. IN VITRO ANTIOXIDANT ACTIVITY 
6.4.1. DPPH RADICAL SCAVENGING ACTIVITY 
Table 17: Percentage inhibition and IC50 values of DPPH radical by Quercetin and 
AEKKC  
Sample Concentration 
(μg/ml) 
% Inhibition IC50 (μg/ml) 
 
 
Standard 
(Quercetin) 
5 32.20  
 
10.79 
10 42.14 
15 53.36 
20 68.33 
25 86.65 
30 94.56 
 
 
AEKKC 
10 22.09  
 
45.35 
20 30.94 
40 42.53 
60 51.21 
80 62.22 
100 79.23 
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Figure 9: DPPH radical scavenging activity of Quercetin 
 
 
 
Figure 10: DPPH radical scavenging activity of AEKKC 
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6.4.2. ABTS RADICAL SCAVENGING ACTIVITY 
Table 18: Percentage inhibition and IC50 values of ABTS radical by Quercetin and 
AEKKC 
Sample Concentration 
(μg/ml) 
% Inhibition IC50 (μg/ml) 
 
 
Standard 
(Quercetin) 
0.25 42.56  
 
0.3869 
0.5 50.34 
0.75 65.12 
1 79.84 
1.25 90.23 
1.5 96.41 
 
 
AEKKC 
1 25.6  
 
3.12 
2 32.6 
4 53.6 
6 69.7 
8 77.4 
10 85.9 
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Figure 11: ABTS radical scavenging activity of Quercetin 
 
 
 
 
Figure 12: ABTS radical scavenging activity of AEKKC 
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6.5. PHARMACOLOGICAL STUDY  
6.5.1. ACUTE TOXICITY TEST 
The acute toxicity test was performed by using the AEKKC at concentrations of 5 mg/kg, 
50 mg/kg, 300 mg/kg and 2000 mg/kg. Toxicity study was performed as per OECD 
guidelines 423. It was observed that the AEKKC was not lethal to the rats at 2000 mg/kg 
dose. Hence the dose fixed for study as 200 mg/kg as low dose and 400 mg/kg as high 
dose. The observations are summarized in table: 
Table 19: Acute toxicity study 
Response Group 1 Group 2 Group 3 Group 4 
Alertness Normal Normal Normal Normal 
Grooming Normal Normal Normal Normal 
Touch response Normal Normal Normal Normal 
Torch response Normal Normal Normal Normal 
Pain response Normal Normal Normal Normal 
Tremor Normal Normal Normal Normal 
Convulsion Normal Normal Normal Normal 
Lighting reflex Normal Normal Normal Normal 
Gripping strength Normal Normal Normal Normal 
Pinna reflex Normal Normal Normal Normal 
Corneal reflex Normal Normal Normal Normal 
Urination Normal Normal Normal Normal 
Salivation Normal Normal Normal Normal 
Skin color Normal Normal Normal Normal 
Lacrimation Normal Normal Normal Normal 
Diarrhoea Normal Normal Normal Normal 
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Figure 13: Anti-inflammatory effect of Diclofenac and AEKKC in carrageenan induced 
paw edema in rats. Each point shows percent inhibition of paw edema after 1, 2, 3, 4 and 
5 h of treatment. 
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 HISTAMINE INDUCED RAT PAW EDEMA METHOD 
Table 21: Effect of AEKKC on Histamine induced rat paw edema in rats 
Group Treatment 
and Dose 
Mean edema volume(ml) and % inhibition 
0 h 1 h 2 h 3 h 
I Histamine 
0.1% (0.1 ml) 
0.066±0.003 0.120±0.002 0.217±0.003 0.3133±0.002 
II Diclofenac  
(20 mg/kg) 
0.067±0.004 0.061±0.0015*** 
(49.166%) 
0.082±0.001*** 
(62.24%) 
0.092±0.001*** 
(70.60%) 
III AEKKC  
(200 mg/kg) 
0.063±0.004 0.101±0.005** 
(15.97%) 
.112±0.001*** 
(48.112%) 
0.130±0.002*** 
(58.46%) 
IV AEKKC  
(400 mg/kg) 
0.064±0.002 0.076±0.002*** 
(36.83%) 
0.095±0.003*** 
(55.89%) 
0.103±0.003*** 
(67.09%) 
 
Values in brackets denote percentage inhibition of the edema paw volume  
Statistical comparison: Values represent mean ± SEM, n=6 compared with control, 
statistical analysis was done by one way analysis of variation (ANOVA) followed by 
Dunnett’s test. ***P<0.001, **P<0.01, *P<0.05 and ns- non significant. 
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Figure 14: Anti-inflammatory effect of Diclofenac and AEKKC in histamine induced paw 
edema in rats. 
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Figure 15: Anti-pyretic effect of Paracetamol and AEKKC in yeast induced pyrexia. 
Each point shows percentage reduction of rectal temperature after 1, 2, 3, 4 and 5 h of 
treatment. 
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6.6. ANTIMICROBIAL ACTIVITY OF AQUEOUS EXTRACT OF KABASURA 
KUDINEER CHOORNAM 
6.6.1. Zone of inhibition 
Table 23: Zone of inhibition for Gram +ve organisms 
Organism Standard (mm) AEKKC (mm) 
Bacillus subtilis 31 mm 10 mm 
Staphylococcus aureus 35 mm 18 mm 
 
 
Table 24: Zone of inhibition for Gram –ve organisms 
Organism Standard (mm) AEKKC (mm) 
E.coli 36 mm 11 mm 
Pseudomonas aeuroginosa 38 mm 15 mm 
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Figure 16: Zone of inhibition for Gram +ve organisms                           
 
 
 
Figure 17: Zone of inhibition for Gram –ve organisms 
 
 
 
 
 
 
 
 
 
Bacillus subtilis 
 
Staphylococcus aureus 
E.coli Pseudomonas aeuroginosa 
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6.6.2. MINIMUM INHIBITORY CONCENTRATION OF AEKKC  
Table 25: MIC values of AEKKC 
Organism MIC value of AEKKC (µg/ml) 
Bacillus subtilis 250 µg/ml 
Staphylococcus aureus 250 µg/ml 
E.coli 250 µg/ml 
Pseudomonas aeuroginosa 250 µg/ml 
 
Figure 18: MIC of AEKKC 
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7. DISCUSSION  
 
In the developing countries increased cost of medicine as well as their side effects 
has become a great task when public health is concerned. From time to time, investigations 
have been carried out to develop different types of polyherbal formulations to enhance the 
overall therapeutic potential of the formulation. And so, nowadays the traditional medical 
system and their herbal / herbo-mineral preparations used for various ailments are 
becoming more popular. 
Siddha medicine is one of the oldest Indian systems of medicine. And it is most 
commonly practiced in India especially in southern regions. In Siddha, Kabasura kudineer 
choornam is widely prescribed for the management and prevention of swine flu. The 
phytochemical constituents present in choornam may responsible for its anti-
inflammatory, antipyretic, analgesic, anti-viral, anti-bacterial, anti-fungal, anti-oxidant, 
hepato-protective, anti-diabetic, anti-asthmatic, anti-tussive, immunomodulatory, anti-
diarrhoeal and anti-oxidant activities. [11] [97] 
The current study deals with the inquiry of the effects of Kabasura kudineer 
choornam in two different animal models of inflammation and one animal model of 
hyperpyrexia. 
Phytochemical screening of AEKKC was carried out and the results showed the 
presence of carbohydrates, glycosides, alkaloids, phenolic, tannin, flavonoids, saponins, 
steroids and triterpenoids. 
The main attraction of the phytochemical was the presence of phenols and 
flavonoids which was concluded by the colorimetric estimation of these constituents in the 
extract. The phenolics, particularly polyphenols exhibit a wide variety of beneficial 
activities in mammals including antiviral, antibacterial, immune stimulating, antiallergic, 
antihypertensive, antiischemic, antiarrhythmic, antithrombotic, hypocholesteromic, 
hepatoprotective, anti-inflammatory, anticarcinogenic actions. Flavonoids are an 
important group of polyphenols and are reported to inhibit prostaglandin synthesis, which 
are known mediators of inflammation. [98] 
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Total phenolic content was determined by using the Folin-Ciocalteu (FC) reagent 
method. Plant phenols constitute the major group of compounds that act primarily as 
antioxidants and free radical scavengers. Hydrogen donating property of the polyphenolic 
compounds is responsible for the inhibition of free radical induced lipid peroxidation. [99] 
The total phenolic content of the AEKKC was found to be 68.27 mg/g calculated as Gallic 
acid equivalent. 
The total flavonoid content present in the AEKKC was determined by Aluminium 
chloride colorimetric method. Flavonoids are natural compunds widely distributed in plant 
kingdom. They have great effect on mammalian enzymes like protein kinases, alpha-
glucosidase and aldose reductase. Thus flavonoids regulate the altered multiple cellular 
signaling pathway during disease conditions. Flavonoids are categorized into 6 major 
subgroups based on their chemical structure such as flavones, chalcones, flavondiols, 
anthocyanins, flavonols and condensed tannins. [100]The total flavonoid content in extract 
was found to be 32.9 mg/g calculated as Quercetin equivalent. 
Inorder to justify and quantify the presence phytoconstituents, the samples was 
subjected to HPTLC screening against marker compounds such as, Gallic acid, Quercetin, 
Rutin, ferrulic acid, andrographolide, ellagic acid.  
From the results obtained from HPTLC study, it was found that 1000 µg of KKC 
in methanol, AEKKC and KKC in water contains both Quercetin & Gallic acid. KKC in 
methanol showed 0.03% of quercetin and 0.140% of gallic acid. While AEKKC was found 
to contain 0.06% of quercetin and 0.37% of gallic acid. Finally KKC in water showed 
0.02% of quercetin and 0.177% of gallic acid. 
Normally about 5% of the inhaled oxygen is converted to harmful ROS like O2 
–, 
H2O2, •OH. In many inflammatory disorders there is excess activation of phagocytes and 
production of superoxide (O2
–) radical which can harm surrounding tissue either by a 
powerful direct oxidizing action or indirectly as with hydrogen peroxide (H2O2) and 
hydroxyl radicals (•OH) formed from superoxide radical. These radicals initiate lipid 
peroxidation and finally results in membrane destruction. The damaged tissue then 
provokes inflammatory response by the production of mediators and chemotactic factors. 
The ROS are also known to activate matrix metalloproteinase (e.g. collagenase) causing  
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increased destruction of tissues. Hence the agents that can scavenge these reactive oxygen 
species can be beneficial in the treatment of such inflammatory disorders. [98] 
Antioxidant potential of AEKKC was determined by using both DPPH and ABTS 
scavenging method. The effect of antioxidants on DPPH is thought to be due to their 
hydrogen donating ability. The free radical scavenging activity of the extract was 
estimated by comparing the percent inhibition of AEKKC with standard Quercetin. The 
IC50 value of extract and quercetin was found to be 45.35 and 10.79 respectively. The result 
showed that the extract has hydrogen donating ability and serve as free radical scavenger. 
ABTS assay is an excellent tool in determining the antioxidant potential of hydrogen 
donating antioxidants (Scavengers of lipid peroxyl radicals). From the results obtained in 
ABTS assay it was found that the extracts scavenged ABTS+ radicals generated by the 
reaction between ABTS and potassium per sulphate. The activity was found to be 
increased in a dose dependent manner. IC50 value of Quercetin and AEKKC was found to 
be 0.3869 and 3.12 respectively. 
Any medicine, whether synthetic or herbal is anticipated to benefit the recipient. 
To validate the safety and efficacy of the same, toxicity studies are of prime importance 
which predicts the potential toxicity of the medicine in human beings exposed to near fatal 
doses. The dose and extent of toxicity of the formulation was found out by acute toxicity 
studies according to OECD guidelines 423 in mice with the AEKKC at doses 5 mg/kg, 50 
mg/kg, 300 mg/kg and 2000 mg/kg. No mortality or morbidity was found till 14 days of 
study. The dose fixed for current study was 200 mg/kg as low dose and 400 mg/kg as high 
dose. 
The anti-inflammatory activity of the AEKKC was evaluated by two experimental 
models, i.e., carrageenan-induced paw edema and histamine induced paw edema. 
Carrageenan induced paw edema model is used to screen the anti-inflammatory activity of 
a drug in the acute phase of inflammation. Edema induced by carrageenan is a biphasic 
event. The first phase (1 hour) involves the release of serotonin and histamine and the 
second phase (> 1 hour) is mediated by prostaglandins. [43] The mean edema volume and 
percentage inhibition was calculated for 5 hours. A significant anti-edematous activity of 
200 mg/kg of AEKKC was observed during the second phase of inflammation, indicating 
the inhibition of prostaglandin release. While in high dose significant antiedematous was  
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observed from the first phase of inflammation. Both doses shows the maximal percentage 
inhibition at 3rd and 4th hours. The decrease in paw edema inhibition at 5th hours may be 
attributed to the termination of test drug action. 
Both doses of extract (200 mg/kg and 400 mg/kg) exerted a significant inhibition 
of 15.97% and 36.83% at 1 h, 48.11% and 55.89% at 2 h, 58.46% and 69.09% at 3 h 
respectively in the histamine induced rat paw edema model. It was observed that the extract 
was capable of inhibiting edema induced by histamine and the effectiveness for 
suppression of edema might be due to the ability of extract to inhibit the synthesis, release 
or action of histamine involved in the inflammation. 
Fever may be due to infection or one of the sequele of tissue damage, inflammation, 
graft rejection, or other disease states. Regulation of body temperature requires a delicate 
balance between production and loss of heat, and the hypothalamus regulates the set point 
at which body temperature is maintained. In fever this set point elevates. Yeast induced 
fever is called pathogenic fever. Its etiology includes production of prostaglandins, which 
set the thermoregulatory center at a lower temperature. [101] 
The present results showed that AEKKC possesses a significant antipyretic effect 
in yeast-provoked elevation of body temperature in rats, and its effect is comparable to 
that of paracetamol (standard drug) from 1 h to 5 h. So inhibition of prostaglandin synthesis 
could be the possible mechanism of antipyretic action of AEKKC as that of paracetamol. 
Also, there are several mediators or multiprocesses underlining the pathogenesis of fever. 
Inhibition of any of these mediators may bring about antipyretic effect. [101] 
The anti-bacterial activity of the extract was measured by observing bacterial free 
zones formed around the discs. The anti-bacterial study was carried out for AEKKC 
against different strain of bacteria (2 Gram + ve and 2 Gram – ve), that are known to cause 
infection in human and plants, by disc diffusion method at 200 μg/disc. The ciprofloxacin 
10 μg/disc was used as standard for bacteria. The standard ciprofloxacin was found to have 
significant antibacterial activity against bacteria. Thus AEKKC was observed to have 
significant antibacterial activity.  
The zone of inhibition was observed for both Gram +ve and Gram –ve bacteria. The 
maximum zone of inhibition (18mm) was observed for Staphylococcus aureus for the  
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Gram +ve organisms. And for Gram –ve organisms the maximum zone of inhibition (15mm) 
was found for Pseudomonas aeuroginosa. 
Minimum Inhibitory Concentration (MIC) is defined as the highest dilution or least 
concentration of the extracts that inhibit growth of organisms. Determination of the MIC 
is important in diagnostic laboratories because it helps in confirming resistance of 
microorganism to an antimicrobial agent and it also monitors the activity of new 
antimicrobial agents. [102] AEKKC were found to have anti-bacterial activity with MIC of 
250 µg/ml for both gram positive and gram negative organism.  
.  
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8. CONCLUSION 
 
The present study supports that aqueous extract of KABASURA KUDINEER 
CHOORNAM (AEKKC) have significant anti-inflammatory, antipyretic and 
antibacterial activity.  
On the basis of the study the formulation showed significant in vitro anti-oxidant activity 
by terminating the actions of free radicals. The AEKKC (200 mg/kg and 400 mg/kg) was 
studied for its anti-inflammatory activity using carrageenan and histamine induced 
inflammation. Diclofenac (20 mg/kg) was used as standard for both the models. The anti-
pyretic activity was evaluated by Brewer’s yeast induced pyrexia model in which 
paracetamol (150 mg/kg) was used as standard.  
Thus the study proved that the AEKKC possesses significant (P<0.05) anti-inflammatory 
activity which was evident with reduction in mean paw edema volume in both carrageenan 
and histamine induced inflammatory models. In antipyretic activity, AEKKC 
demonstrated significant (P<0.05) protection by reducing yeast evoked elevated body 
temperature which is comparable to standard drug. Antibacterial activity was evaluated 
via disk diffusion method. The potential activity of extract may be due to the presence of 
phenols, flavonoids and other phytochemical constituents present in it. 
Thus from the above results it was concluded that the AEKKC showed anti-oxidant 
activity and promising anti-inflammatory, antipyretic and antibacterial activity. 
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